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ABSTRACT
CAUSAL INFERENCE METHODS FOR ADDRESSING CENSORING BY
DEATH AND UNMEASURED CONFOUNDING USING INSTRUMENTAL
VARIABLES

Fan Yang
Dylan Small, Edward George

This thesis considers three problems in causal inference. First, for the censoring
by death problem, we propose a set of ranked average score assumptions making use
of survival information both before and after the measurement of a non-mortality
outcome to tighten the bounds on the survivor average causal effect (SACE) obtained in the previous literature that utilized survival information only before the
measurement. We apply our method to a randomized trial study of the effect of
mechanical ventilation with lower tidal volume vs. traditional tidal volume for
acute lung injury patients. Our bounds on the SACE are much shorter than the
bounds obtained using only the survival information before the measurement of the
non-mortality outcome. Second, for the IV method with nonignorable missing covariates problem, we develop a method to estimate the causal effect of a treatment
in observational studies using an IV when there are nonignorable missing covariates, i.e., missingness depending on the partially observed compliance class besides
the fully observed outcome, covariates and IV. We apply our method to a motivativ

ing study in neonatal care to study the effectiveness of high level compared to low
level NICUs. Third, besides the association with the treatment, there are two key
assumptions for the IV to be valid: (i) the IV is essentially random conditioning
on observed covariates, (ii) the IV affects outcomes only by altering the treatment,
the so-called “exclusion restriction”. These two assumptions are often said to be
untestable; however, that is untrue if testable means checking the compatibility of
assumptions with other things we think we know. A test of this sort may result in
an aporia. We discuss this subject in the context of our on-going study of the effects
of delivery by cesarean section on the survival of extremely premature infants of
23-24 weeks gestational age.
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Chapter 1
Introduction
Causal inference is a central aim of many medical studies and social science studies
where the goal is to identify the impact of a treatment or exposure on outcomes of
interest, for instance, the effect of smoking on lung cancer. In this thesis, we focus
on three problems that complicate the analysis of experiments and observational
studies to draw causal conclusions, namely, the censoring by death problem, the IV
method with nonignorable missing covariates and testing the validity of an IV.
Many clinical studies where the effect of treatment on a non-mortality outcome
is of interest are complicated by censoring by death – for those patients who die
before the measurement of non-mortality outcome, their non-mortality outcomes
are not measured or well-defined. This is a special type of missing data. Even in
randomized experiments with perfect compliance, a direct comparison of the nonmortality outcomes among the survivors in treatment vs. control could be biased
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because censoring by death is typically informative since patients who die usually
would have had bad non-mortality outcomes compared to those who did not die even
if the dead patients could have somehow been kept alive. To address this problem,
we focus on a well defined causal estimand-the survivor average causal effect (SACE)
(Rubin, 2000; Frangakis and Rubin, 2002)- which is the effect of treatment on the
non-mortality outcome among subjects who would survive under both treatment
and control to the time point when the non-mortality outcome is measured. The
SACE is not point identified without strong untestable assumption; however, with
reasonable assumptions, it can be bounded (Zhang and Rubin, 2003; Imai, 2008;
Chiba, 2012). In the previous literature on bounding the SACE, only the survival
information before the measurement on the non-mortality outcome has been used.
With limited information used, the bound is generally wide. In most clinical studies,
the information is not restricted to the treatment the patient received, the outcome
of interest and the survival information before the measurement of this outcome.
In this thesis, based on the fact that the survival information after measurement of
non-mortality outcome is also informative as a proxy of the severity of conditions
of subjects, we proposed a set of ranked average score with two stage survival
information assumptions which are plausibly satisfied in many quality of life studies
and developed a two-step linear programming approach to obtain the closed form
of the bound of the SACE under our assumptions. By utilizing both the survival
information before and after the measurement of non-mortality outcome, inferences

2

on the SACE could be sharpened. Both numerical examples and an application to a
critical care study illustrate the benefit of utilizing the further outcome information
of survival. We also extend our method to bound the complier survivor average
causal effect (CSACE) in randomized trials with noncompliance or observational
studies where a valid instrumental variable is available.
The work on the IV method with nonignorable missing covariates is motivated
by an observational study of neonatal care that aims to estimate the effect on mortality of premature babies being delivered in a high level NICU (neonatal intensive
care units that have the capacity for sustained mechanical assisted ventilation and
high volume) vs. a low level NICU. This study is complicated by unmeasured confounders as well as nonignorable missing covariates. To control for unmeasured
confounders, we adopt the IV approach. An IV is a variable that is (i) associated
with the treatment, (ii) has no direct effect on the outcome, and (iii) is independent
of unmeasured confounders conditional on measured confounders. In the neonatal
care study, we consider the use of excess travel time as an instrumental variable
(IV) to control for unmeasured confounders. However, some confounders of the IV
- outcome relationship we must condition on in order for our IV to be valid are not
completely recorded and the missingness of those covariates may depend on only
partially observed compliance status (i.e., whether the choice of treatment complies
with the IV encouragement) besides the fully observed outcome, fully observed
covariates and IV. Many observational studies face similar issues of unmeasured

3

confounding and nonignorable missing covariates, for example, in comparative effectiveness studies, it is a concern that the missingness of important lab values
might be related with compliance status. Thus, developing an approach that can
account for both issues is of real need. Previous literature on IV with nonignorable
missing data focused on outcomes (Frangakis and Rubin, 1999; Mealli et al., 2004;
Peng et al.(2004); Chen et al., 2009; Small and Cheng, 2009). In this literature,
it has been argued that ignorability of the missing outcome may only be plausible
after conditioning on the covariates and the partially observed compliance status.
Methods have been developed for estimating causal effects under this ”latent ignorability”. However, no literature we are aware of addressed the problem of IV with
nonignorable missing covariates. In this thesis, a method is developed to address
the above issues. We proposed a series of models to estimate the causal effect of
a treatment when a valid IV is available under our nonignorable missingness assumption which assumes that the missingness of covariates is ignorable conditional
on the fully observed outcome, the fully observed covariates, the IV as well as the
partially observed compliance behavior. Simulation studies indicate that when the
missingness of covariates is related to the partially observed compliance behavior,
even if the missing rate of covariates is low and the effect of compliance status on
the missingness is only moderate, the commonly used estimation methods, complete
case analysis and multiple imputation by chained equations assuming missingness
at random, provide substantially biased estimates, while our method, which is de-
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signed to deal with nonignorable missingness of covariates, provide approximately
unbiased estimates. By extending the proposed series of models to allow for an
unmeasured confounder’s effects on both outcome and missingness, one can assess
the sensitivity of the causal conclusions to a deviation from our nonignorable missingness assumption.
The IV method is widely used in observational studies (Angrist and Krueger,
1991; Baiocchi et al., 2010; Yang, Lorch and Small, 2014). Besides the association
with the treatment, there are two key assumptions for the IV to be valid: (i) the IV
is haphazard or essentially random once adjustments have been made for observed
covariates, (ii) the IV affects outcomes only by altering the treatment, the so-called
”exclusion restriction”. These two assumptions are often said to be untestable
(e.g., Morgan and Winship 2007, p.196). Our point of view is that if one confined
attention to the information in the target study itself - namely, the confounders
measured, the IV, treatment and outcome - then perhaps there is no way to test IV
assumptions, however, it is often possible to check the IV assumptions against other
things we think we know. In this thesis, we suggest that a test of IV assumptions
may lead neither to rejection of the assumptions nor to acceptance but rather to
an aporia. An aporia is a collection of propositions such that each one is plausible
on its own but they are jointly inconsistent. We discuss this subject in the context
of an ongoing study I am collaborating on about the effect of delivery by cesarean
section on the survival of extremely premature infants of 23-24 weeks gestational
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age. We proposed as an IV the cesarean section rate at the hospital at which the
baby was delivered; similar IVs of how often a procedure is performed at a hospital
or in a geographic region have been used in many health care studies (Brookhart
and Schneeweiss, 2007) We applied to the data a new bipartite matching algorithm
to strengthen this instrumental variable. Under the assumption that the IV is valid,
we found strong evidence that cesarean sections increase the survival of premature
infants of 23-24 weeks gestational age. To test the validity of our IV, we used the fact
that the literature claims that for older preterm babies of 30-34 weeks gestational
age, there is no benefit from cesarean section (Werner et al., 2013; Malloy, 2009).
We used the same IV and applied the same matching procedure on older preterm
babies, say 30-34 weeks gestational age. There are two possible results: (i) there
is no evidence of the benefit from cesarean section for infants of 30 - 34 weeks
gestational age using the IV proposed which agrees with the literature, then we
are more confident about the validity of our IV thus more comfortable with the
causal conclusion we obtained for the infants of 23-24 weeks gestational age; (ii)
there is evidence from the IV analysis that cesarean sections benefit 30-34 week old
babies, which contradicts to the current literature. In our analysis of the data, we
obtained result (ii). This creates an aporia – the assumption that the IV is valid and
the literature that says that cesarean sections don’t benefit 30-34 week old babies
cannot both be right. This is an advance in understanding, albeit recognizing an
aporia is an uncomfortable one, but it is certainly better than believing each claims
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without recognizing their aporetic status.
The rest of this thesis is organized as follows.
In Chapter 2, we discuss the problem of censoring by death. Section 2.1 provides a detailed introduction to this problem. In section 2.2, we introduce notation
and assumptions to set up the causal framework. In section 2.3, we present the
derivations of the bounds of SACE and provide some numerical examples to compare the bounds derived with the bound using one set of assumptions in Zhang and
Rubin (2003). We extend our method to IV settings in section 2.4. In section 2.5,
we discuss how to check the plausibility of our assumptions for the ”large sample”
data as well as the sample data. We discuss the confidence intervals for bounds in
section 2.6, and we apply our approach to the tidal volume study in section 2.7.
Conclusions and discussions are presented in section 2.8.
In Chapter 3, we discuss the IV method with nonignorable missing covariates.
Section 3.1 provides a detailed introduction to this problem. In section 3.2, we
introduce notation and assumptions to set up the causal framework. In section 3.3,
we present our model for inference about complier average causal effect (CACE) and
EM algorithm to estimate parameters involved in the model. A simulation study is
be provided in section 3.4, and we study how the estimates of CACE can be affected
by wrong assumptions about missing mechanisms. Then, we apply our approach to
the neonatal care data in section 3.5, and conduct the sensitivity analysis in section
3.6. Conclusions are presented in section 3.7.
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In Chapter 4, we discuss the aporetic conclusions when testing the validity of an
IV. Section 4.1 provides an introduction to this problem. In section 4.2, we discuss
some backgroud, present the IV analysis, test the IV assumptions and discuss in
detail resulting in an aporia. A summary is presented in section 4.3.
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Chapter 2
Two-stage Censoring by Death

2.1

Introduction

In many clinical studies, researchers are interested in the effect of a treatment on
a non-mortality outcome such as complications or quality of life in addition to
mortality. However, the assessment of the causal effect on non-mortality outcomes
of interest is often complicated by censoring by death. This censoring by death
occurs because, by the time the non-mortality outcome is measured, some patients
have died and thus the non-mortality outcome cannot be measured or is not well
defined for these dead patients. For example, suppose we want to study the effect on
intraventricular hemorrhage (IVH) of premature babies being delivered in a highlevel neonatal intensive care unit (NICU) vs. a lower-level NICU. IVH is rarely
present at birth but usually occurs in the first several days of life ( See Lee, 2013).

9

If the baby died before being born (a fetal death) or shortly after birth, then whether
the baby had IVH is not well-defined. Another example is that in cancer studies,
quality of life outcomes that might be measured six months or a year after treatment
like incidence of fatigue, myelosuppression and treatment side-effects (e.g., Motzer
et al., 2013) are important outcomes considered to assess the efficacy of a treatment.
However, patients may die before the measurement of the quality of life outcomes;
for those patients, the quality of life outcomes are not well-defined. Censoring by
death is typically informative – patients who die usually would have had worse
quality of life than those who did not die even if the dead patients could have
somehow been kept alive (Cox et al., 1992). Furthermore, those patients who are
saved by a treatment are often sicker patients on average than those patients who
would live under both treatment and control. Consequently, a direct comparison
of the non-mortality outcomes among the survivors in treatment vs. control would
be biased. To address the fundamental problems that the non-mortality outcomes
are not well defined for those who die before measurement and that the censoring
of the measurement is informative, Rubin (2000), and Frangakis and Rubin (2002)
proposed a well defined causal estimand – the survivor average causal effect (SACE)
– which is the effect of treatment on the non-mortality outcome among patients who
would survive under both treatment and control to the time point when the nonmortality outcome is measured.
Without strong untestable assumptions, the SACE is not point identified; how-
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ever, with reasonable assumptions, we can obtain an interval in which SACE will
lie. Zhang and Rubin (2003) discussed various assumptions (ranked average score
assumptions) that can be made to bound the SACE, and derive large sample bounds
in a randomized trial. Imai (2008) provided an alternative proof that the bounds
obtained in Zhang and Rubin (2003) are sharp and generalized the proof to obtain
sharp bounds on the quantile treatment effect. Chiba (2012) proposed a number of
assumptions that are different from the ranked average score assumptions in Zhang
and Rubin (2003) and derived the corresponding bounds. Another stream of work
on drawing inference about the SACE is through sensitivity analysis procedures,
for instance, Hayden et al. (2005), Egleston et al. (2007), and Chiba and VanderWeele (2011). A problem similar to censoring by death arises in evaluating the
effect of vaccine vs. placebo on post-infection outcomes. Hudgens, Hoering and Self
(2003) developed tests for the causal effect on viral load among the individuals who
would be infected no matter whether they received the vaccine regimen or a placebo
regimen. Gilbert, Bosch and Hudgens (2003) proposed a class of models indexed
by an interpretable sensitivity parameter, where the SACE is identified given the
sensitivity parameter.
In the previous literature on bounding the SACE, only the survival information
before the measurement on the non-mortality outcome has been used. However,
survival information after measurement may be informative. In this chapter, we
develop a method to use both the survival information before and after the mea-
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surement of non-mortality to sharpen inferences on the SACE in the setup of randomized experiments. We will also present an extension of our method to bound
the complier survivor average causal effect (CSACE) in a randomized trial with
noncompliance or an observational study where an instrumental variable (IV) is
available.
We will apply our method to the ARDSNet study, a randomized clinical trial
on the effect of mechanical ventilation with lower tidal volumes vs. traditional tidal
volumes for patients suffering from acute lung injury (The Acute Respiratory Distress Syndrome Network, 2000). The trial found evidence that lower tidal volumes
reduce mortality. The investigators were also interested in assessing the effect of
lower tidal volumes on a quality of life (QOL) outcome, whether the patient was
able to breathe without assistance by day 28. In the data, both survival at day
28, when the QOL is measured, and whether the patient was ultimately discharged
home alive, post-QOL measurement survival information, are recorded. Utilizing
the post QOL measurement survival information in addition to the pre-QOL measurement survival information, we are able to substantially sharpen the bounds on
the SACE for the effect of lower tidal volume on being able to breathe without
assistance by day 28.

12

2.2

Notation and Assumptions: Randomized Experiment with Perfect Compliance

In this section and the following, we focus on two arm randomized experiments
where the subjects are randomly assigned to either treatment or control. The
method is extended to IV settings in section 2.4.

2.2.1

Notation

We use the potential outcomes approach to define causal effects. Let Di represent
the binary treatment for the ith subject; we call level 1 “the treatment” and level
0 “the control”. Let D denote the vector of treatment assignment indicators for
all subjects. Let S1i (d) be the potential survival indicator of subject i that would
be observed at the first time point after which the measurement of non-mortality
outcome is taken, with 0 indicating death, 1 if alive. Let Yi (d) represent the potential non-mortality binary outcome (for instance, complication of babies, QOL
of participants ) that would be observed under treatment assignment d. The nonmortality outcome is measured after the first time point, thus if the subject would
die before that time point (S1i (d) = 0), Yi (d) is not defined. For convenience, we
assume that level 1 of the non-mortality outcome is worse than level 0 of the outcome, e.g., in the ARDSNet study, level 1 indicates that the patient was not able to
breathe without assistance by day 28 and level 0 indicates the patient was able to
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breathe without assistance by day 28. We further define S2i (d) to be the potential
indicator of survival at the second time point for subject i that would be observed
if under treatment assignment d. If S1i (d) = 0, then S2i (d) = 0 by definition.
We use Di , S1i , Yi and S2i to denote respectively the observed treatment received,
observed survival indicator at the first time point, observed non-mortality outcome
and observed survival indicator at the second time point for subject i.

2.2.2

Assumptions

We assume that the following assumptions hold for randomized experiments.
Assumption 1. Stable unit treatment value assumption (SUVTA).
• If di = d0i , then S1i (d) = S1i (d0 ), S2i (d) = S2i (d0 ), and Yi (d) = Yi (d0 )
SUVTA means that there is no interference between subjects so that a subject’s
outcome only depends on the subject’s own treatment. Under SUVTA, each subject
has two potential first time point survival outcomes (S1i (1), S1i (0)), based on values
of which we can classify subjects into four groups:
• 11 = {i|S1i (1) = 1, S1i (0) = 1}, always survivors: the subjects that would
survive at least to the first time point under both treatment arms,
• 10 = {i|S1i (1) = 1, S1i (0) = 0}, protected: the subjects that would survive at
least to the first time point under treatment, but would die before then under
control;
14

• 01 = {i|S1i (1) = 0, S1i (0) = 1}, harmed: the subjects that would die before
the first time point under treatment, but would survive at least to the first
time point under control;
• 00 = {i|S1i (1) = 0, S1i (0) = 0}, never survivors: the subjects that would die
before the first time point under both treatment arms;
Assumption 2. The assignment Di of each subject is independent of his/her
potential outcomes.
Assumption 3. Monotonicity: S1i (1) ≥ S1i (0), S2i (1) ≥ S2i (0). There is no 01
(harmed) group.
The monotonicity assumption says that the treatment does not cause death,
which is often plausible in practice. Under this assumption, subjects could either
be “always survivors”, “protected” or “never survivors”. The most meaningful
inference of causal effect of treatment on Y can be drawn only for the “always
survivors”, because it is the only group for which both Yi (1) and Yi (0) are well
defined, see Rubin (2000), Frangakis and Rubin (2002). Define the survivor average
causal effect (SACE) as E(Yi (1) − Yi (0) | 11), which is our quantity of interest.
We further create finer strata based on the possible combinations of potential
survival at both the first (QOL measurement point) and second (post-QOL measurement point) time points, which is described in Table 2.1.
The always survivors at time point 1 are divided into the following three subgroups: 1111, always survivors who would live at least to the second time point
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Table 2.1: Fine Strata
Probability S1i (1) S1i (0) S2i (1) S2i (0) Principal Strata at Time Point 1
π1111

1

1

1

1

Always survivors

π1110

1

1

1

0

Always survivors

π1100

1

1

0

0

Always survivors

π1010

1

0

1

0

Protected

π1000

1

0

0

0

Protected

π0000

0

0

0

0

Never survivors

under both treatment arms; 1110, always survivors who would survive at least to
the second time point under treatment, but would die before then under control;
1100, always survivors who although they can live at least to the first time point,
would die before the second time point under both treatment arms. The protected
at time point 1 are combinations of the following two subgroups: 1010, subjects
who would live at least to the second time point under treatment, but would die
before the first time point under control; 1000, subjects who if they receive treatment would live at least to the first time point but would die before the second time
point, but if they receive control, would die even before the first time point. Never
survivors comprise a single subgroup which we denote as 0000 because the second
time point death indicator provides no additional information for them.
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In terms of our fine strata, the SACE is expressed as:
SACE = E(Yi (1) − Yi (0) | S1i = S1i (0) = 1)
= P (Yi (1) = 1 | S1i (1) = S1i (0) = 1) − P (Yi (0) = 1 | S1i (1) = S1i (0) = 1)
=

(π1111 E(Yi (1) | 1111) + π1110 E(Yi (1) | 1110) + π1100 E(Yi (1) | 1100))
π1111 + π1110 + π1100

−

(π1111 E(Yi (0) | 1111) + π1110 E(Yi (0) | 1110) + π1100 E(Yi (0) | 1100))
π1111 + π1110 + π1100

(2.2.1)

Plausible assumptions can be made on data to tighten the bounds of SACE. Zhang
and Rubin (2003) proposed the assumption that when assigned treatment, on average, the outcome for “always survivors” is better than “protected”, in our case, that
is to say P (Yi (1) = 1 | 11) ≤ P (Yi (1) = 1 | 10), recalling that we use 1 to denote
worse outcome for Y. This uses only the information on death before the measurement of the non-mortality outcome. In the rest of this chapter, we will refer to this
assumption as the ranked average score with one stage survival information assumption. Survival information after measurement of the non-mortality outcome may
deliver finer information, making use of which can help us make more reasonable assumptions and sharpen inferences. We will refer to the following set of assumptions
as ranked average score with two stage survival information assumptions.
Assumption 4. Among always survivors at time point 1, the probability of worse
outcome for group 1111 is the lowest, whereas the probability of worse outcome for
group 1100 is the highest under both treatment arms:
P (Yi (1) = 1 | 1111) ≤ P (Yi (1) = 1 | 1110) ≤ P (Yi (1) = 1 | 1100)
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(2.2.2)

P (Yi (0) = 1 | 1111) ≤ P (Yi (0) = 1 | 1110) ≤ P (Yi (0) = 1 | 1100)

(2.2.3)

Assumption 5. Among protected at time point 1, the probability of worse outcome for group 1010 is no higher than that for group 1000 under treatment:
P (Yi (1) = 1 | 1010) ≤ P (Yi (1) = 1 | 1000)

(2.2.4)

Assumption 6. Under treatment, the probability of worse outcome for group
1100 is not lower than that for group 1010, but not higher than that for group
1000, and the probability of worse outcome for group 1110 is not higher than that
for group 1010:
P (Yi (1) = 1 | 1110) ≤ P (Yi (1) = 1 | 1010) ≤ P (Yi (1) = 1 | 1100) ≤ P (Yi (1) = 1 | 1000)
(2.2.5)

Assumptions 4, 5 and 6 are plausibly satisfied in many QOL studies. Consider the
ARDSNet study of the effect of lower tidal volumes (treatment) vs. traditional
tidal volumes (control) on being able to breathe without assistance by day 28 in
the ICU described in the introduction, where the post-QOL measurement survival
time point is being discharged home alive. Assumption 4 says, among patients
who would survive to day 28 under both treatment and control, those patients who
would be discharged home alive under both treatment and control are healthiest at
day 28 on average, and those who would be discharged home alive under treatment
but not control are healthier at day 28, than those who would die in the hospital
under both treatment and control. Assumption 5 says, among patients who would
survive to day 28 only under treatment, those patients who would ultimately be
18

discharged home alive under treatment are healthier on average than patients who
would ultimately die in the hospital. Assumptions 4 and 5 are plausible because
being discharged home alive is a proxy for health at day 28. Assumption 6 is
a comparison of the 1010 patients who would die before day 28 under control but
survive to day 28 and be discharged home alive under treatment, to the 1100 patients
who would survive to day 28 under both treatment and control but die in the
hospital after day 28 under both treatment and control. Assumption 6 says that
under the treatment, the 1010 patients tend to be healthier than the 1100 patients
at day 28. This is plausible for the ARDSNet study for the following reasons. The
1100 patients are likely to be fairly sick by day 28 under the treatment since these
patients will die in the ICU. In contrast, the 1010 patients are likely to be less sick
on day 28 under the treatment because they will be (or already have) discharged
home alive. An example of a 1010 patient would be a patient who was healthy
but suffered a gunshot wound that caused an acute lung injury. When the patient
arrives at the ICU, the patient is in critical condition and only the treatment will
save the patient, but if the patient receives the treatment, the patient’s health before
the gunshot wound will enable the patient to recover well and be regaining his or
her health by day 28. In summary, assumptions 4, 5 and 6 are plausible for the
ARDSNet study.
The ranked average score with one stage survival information assumption is
different from our ranked average score with two stage survival information as-
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sumptions. The major difference is that the one-stage survival assumption assumes
that always survivors, on average, have better QOL outcome than the protected,
whereas our two-stage survival assumptions assume that one particular always survivors group, 1100, has worse QOL outcome than a particular protected group,
1010, on average under treatment, which is a more reasonable assumption for the
ARDSNet study. The differences in the bounds obtained under the ranked average
score with one stage survival information assumption and our two stage survival
information assumptions are presented in numerical examples and the analysis of
ARDSNet study in section 2.3.3 and 2.7 respectively.

2.3

Derivations of Bounds

Under assumptions 1-6, the SACE is not point identified based on the knowledge of
the observable joint distribution of (Di , S1i , S2i , Yi ). However, we can use that joint
distribution to obtain an interval in which the SACE must lie. We first derive the
bounds for the proportions in each stratum, then for fixed proportions we derive
the bounds for the SACE. In this section, we assume that the joint distribution of
(Di , S1i , S2i , Yi ) is known; in section 2.6, we will discuss forming confidence intervals
for the bounds that acknowledge sample uncertainty.
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2.3.1

Bounds for proportions of each stratum

Notice that the observable strata of (Di , S1i , S2i ) are mixtures of fine strata (Table
1). Thus we can express the proportions of strata of (Di , S1i , S2i ) by proportions
of fine strata. Combining this with the fact that all the proportions in the fine
strata must lie between 0 and 1, we can obtain the bounds for each fine stratum’s
proportion. We use ps1 s2 |d to denote P (S1i = s1 , S2i = s2 | Di = d). The following
equations hold:

p11|1 = π1111 + π1110 + π1010

(2.3.1)

p10|1 = π1100 + π1000

(2.3.2)

p00|1 = π0000

(2.3.3)

p11|0 = π1111

(2.3.4)

p10|0 = π1110 + π1100

(2.3.5)

p00|0 = π1010 + π1000 + π0000

(2.3.6)

0 ≤ π1111 , π1110 , π1100 , π1010 , π1100 , π1000 , π0000 ≤ 1

(2.3.7)

Further we have,

Given (2.3.1)-(2.3.6), we can express each π by functions of pss|d and π1100 :
π1111 = p11|0
π1110 = p10|0 − π1100
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π1010 = p11|1 − p11|0 − p10|0 + π1100
π1000 = p10|1 − π1100
π0000 = p00|1
and subject to the constraint of (2.3.7), we have,
max{0, p11|0 + p10|0 − p11|1 } ≤ π1100 ≤ min{p10|0 , p10|1 }

2.3.2

(2.3.8)

Bounds for the SACE

In this step, we first derive the bounds for the SACE with known proportions of
each fine stratum, then will combine the result with the bounds obtained in section
2.3.1 to construct the final bounds for the SACE.
The observable strata of (Yi , S1i , S2i | Di ) are mixtures of potential outcomes
from the fine strata. Letting qys1 s1 |d denote P (Yi = y, S1i = s1 , S2i = s2 | Di = d),
we have the following identities:
q111|1 = π1111 E(Yi (1) | 1111) + π1110 E(Yi (1) | 1110) + π1010 E(Yi (1) | 1010) (2.3.9)
q110|1 = π1100 E(Yi (1) | 1100) + π1000 E(Yi (1) | 1000)

(2.3.10)

q111|0 = π1111 E(Yi (0) | 1111)

(2.3.11)

q110|0 = π1110 E(Yi (0) | 1110) + π1100 E(Yi (0) | 1100)

(2.3.12)
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Recall that
(π1111 E(Yi (1) | 1111) + π1110 E(Yi (1) | 1110) + π1100 E(Yi (1) | 1100))
π1111 + π1110 + π1100
(π1111 E(Yi (0) | 1111) + π1110 E(Yi (0) | 1110) + π1100 E(Yi (0) | 1100))
−
π1111 + π1110 + π1100

SACE =

(2.3.13)
Given π 0 s,

(π1111 E(Yi (0)|1111)+π1110 E(Yi (0)|1110)+π1100 E(Yi (0)|1100))
π1111 +π1110 +π1100

=

q111|0 +q110|0
π1111 +π1110 +π1100

which

is point identified. Thus to bound the SACE, we only need to bound π1111 E(Yi (1) |
1111) + π1110 E(Yi (1) | 1110) + π1100 E(Yi (1) | 1100), which defines a linear programming problem:
min / max

(π1111 E(Yi (1) | 1111) + π1110 E(Yi (1) | 1110) + π1100 E(Yi (1) | 1100)) | π1100
(2.3.14)

Subject to:

q111|1 = π1111 E(Yi (1) | 1111) + π1110 E(Yi (1) | 1110) + π1010 E(Yi (1) | 1010)

(2.3.15)

q110|1 = π1100 E(Yi (1) | 1100) + π1000 E(Yi (1) | 1000)

(2.3.16)

E(Yi (1) | 1111) ≤ E(Yi (1) | 1110) ≤ E(Yi (1) | 1100)

(2.3.17)

E(Yi (1) | 1010) ≤ E(Yi (1) | 1000)

(2.3.18)

E(Yi (1) | 1110) ≤ E(Yi (1) | 1010) ≤ E(Yi (1) | 1100) ≤ E(Yi (1) | 1000)

(2.3.19)

0 ≤ E(Yi (1) | 1111), E(Yi (1) | 1110), E(Yi (1) | 1100), E(Yi (1) | 1010), E(Yi (1) | 1000) ≤ 1
(2.3.20)

where constraints (2.3.17)-(2.3.19) are imposed by assumptions 4-6.
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The above linear programming problem has a solution if and only if
q111|1
,
p11|1

q110|1
p10|1

≥

which is an inequality that must be satisfied based on assumptions 4-6. For

each possible value of π1100 , we solve the above linear programming problem; then,
combining this result with the bound for π1100 derived in section 2.3.1 that π1100 ∈ I,
where I = [max{0, p11|0 + p10|0 − p10|1 }, min{p10|0 , p10|1 }], we have,
min SACE =

=

min

π1100 ∈I

[

min((π1111 E(Yi (1) | 1111) + π1110 E(Yi (1) | 1110) + π1100 E(Yi (1) | 1100)) | π1100 ) − (q111|0 + q110|0 )

π1111 + π1110 + π1100

q
+q
−p
−p
+p
+p
q111|0 +q110|0

111|1
110|1
11|1
10|1
11|0
10|0 q111|1


, p
}− p
,
max{
p
+p
+p

if p11|0 + p10|0 − p11|1 ≥ 0


q
p
+q
(p
+p10|0 −p11|1 )
q111|0 +q110|0


max{0, 111|1 10|1 110|1 11|0
}− p
,
+p
p
(p
+p
)

if p11|0 + p10|0 − p11|1 < 0

11|0

10|1

max SACE =

=

max

π1100 ∈I

q111|1
p11|1

[

−

10|0

11|0

11|1

11|0

11|0

10|0

10|0

10|0

]

(2.3.21)

max((π1111 E(Yi (1) | 1111) + π1110 E(Yi (1) | 1110) + π1100 E(Yi (1) | 1100)) | π1100 ) − (q111|0 + q110|0 )
π1111 + π1110 + π1100
q111|0 + q110|0
p11|0 + p10|0

+

q110|1 p11|1 − q111|1 p10|1
p10|1 p11|1 (p11|0 + p10|0 )

· min{p10|0 , p10|1 }

]

(2.3.22)

The details of the calculation for the bounds of SACE are provided in the Appendix.

2.3.3

Numerical Examples

Example 1
Assume that the underlying truth about the population is described by Table 2.2.
The SACE = 0.05, meaning that the treatment will increase the probability of the
worse non-mortality outcome by 0.05 among always survivors who will survive at
least to the first time point under both treatment and control.
Suppose that we have an infinite sample, then we would observe that
p11|1 = 0.65

p10|1 = 0.2

p00|1 = 0.15

p11|0 = 0.5

p10|0 = 0.15

p00|0 = 0.35
(2.3.23)
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Table 2.2: Setup 1
% of population

Fine Strata

% of Yi (1) = 1

% of Yi (0) = 1

50

1111

10

5

10

1110

20

15

5

1100

40

35

5

1010

30

-

15

1000

50

-

15

0000

-

-

q111|1 = 0.085

q110|1 = 0.095

q111|0 = 0.025

q110|0 = 0.0325

(2.3.24)

Given the constraints imposed by the observed data (2.3.23)-(2.3.24) and assumptions 4-6, we obtain the bound for SACE: [0.042, 0.122], showing that the treatment
increases the probability of the worse non-mortality outcome.
However, if we don’t use the second time point survival information, the observed
data would be:

P (S1i = 1|Di = 1) = 0.85
P (Yi = 1, S1i = 1|Di = 1) = 0.18

P (S1i = 1|Di = 0) = 0.65

(2.3.25)

P (Yi = 1, S1i = 1|Di = 0) = 0.0575 (2.3.26)

Then, given the constraints imposed by the observed data (2.3.25)-(2.3.26) and the
ranked average score with one stage survival assumption, the bound we would obtain
for the SACE is [-0.088, 0.123], according to which we wouldn’t know whether or
not the treatment increases the probability of the worse non-mortality outcome even
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Table 2.3: Setup 2
% of population

Fine Strata

% of Yi (1) = 1

% of Yi (0) = 1

50

1111

10

5

15

1110

20

15

5

1100

40

35

5

1010

30

-

10

1000

50

-

15

0000

-

-

though the true SACE is positive. From this example, we see that making use of
the survival information after measurement may provide us with more information
and narrow the bounds on the SACE.

Example 2
Through elementary calculation, one can easily prove that the lower bound for
the SACE under our assumptions 4-6 will be at least equal to or larger than the
lower bound for SACE under the ranked average score with one stage survival
information assumption. However, the upper bound under our two stage survival
information assumption is not comparable with the upper bound under one-stage
survival assumption. Our upper bound can be smaller as shown in Example 1, but
it can also be larger as we show below. Assume that the underlying truth about
the population is described by the following Table 2.3.
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The true SACE is 0.05. If we have an infinite sample, then we would have the
following observed data:

p11|1 = 0.7

p10|1 = 0.15

p00|1 = 0.15

p11|0 = 0.5

p10|0 = 0.2

p00|0 = 0.3
(2.3.27)

q111|1 = 0.095

q110|1 = 0.07

q111|0 = 0.025

q110|0 = 0.04

(2.3.28)

Given the constraints imposed by the observed data (2.3.27)-(2.3.28) and assumptions 4-6, we obtain the bounds for the SACE: [0.043, 0.114]. If we don’t
utilize the second time survival information, we would observe the following data:

P (S1i = 1|Di = 1) = 0.85
P (Yi = 1, S1i = 1|Di = 1) = 0.165

P (S1i = 1|Di = 0) = 0.7

(2.3.29)

P (Yi = 1, S1i = 1|Di = 0) = 0.065 (2.3.30)

Then, given the constraints imposed by the observed data (2.3.29)-(2.3.30) and the
ranked average score with one stage survival information assumption, the bound
we would obtain for the SACE is [-0.071, 0.101]. In this setup, the upper bound
under the ranked average score with two stage survival information assumption
(Assumption 4-6) is larger than that of the ranked average score with one stage
survival information assumption. The reason is that the ranked average score with
two stage survival information assumptions allow for the possibility that the always
survivors’ (1111, 1110, 1100) probability of bad outcome exceed the protecteds’
(1010, 1000) probability of bad outcome which contradicts the ranked average score
with one stage survival information assumption.
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2.4

Extension to IV settings

The idea of using second time point survival information to sharpen the inference of
SACE under randomized trials with perfect compliance can be naturally extended
to randomized trials with noncompliance or observational studies with a valid IV
to obtain inference about the complier survivor average causal effect (CSACE). In
a randomized trial with noncompliance, the assignment of treatment can be used
as an IV to assess the effects of receiving the treatment on the outcome. In observational studies, natural experiments such as a person’s draft lottery number,
randomly assigned federal judges or quarter of birth have been used as IVs. (Angrist, 1990; Angrist and Krueger, 1991; Kling, 1999). For more literatures on IV, see
Angrist, Imbens, and Rubin (1996), Abadie (2002), Hernan and Robins (2006), Tan
(2006), Brookhart and Schneeweiss (2007), Cheng (2009), and Clarke and Windmeijer (2012).
Let Zi represent the binary IV; 1 encourages the treatment for the ith subject
and 0 does not provide encouragement of the treatment. We use Z to denote the
vector of IV for all subjects. Let Di (z) be the potential binary treatment variable
that would be observed under IV assignment z for subject i; 1 being the treatment
and 0 denotes the control. Let S1i (z) be the potential survival indicator of subject
i that would be observed at the first time point after which the measurement of
non-mortality outcome is taken; with 0 indicating death, 1 if alive. Let Yi (z)
represent the potential non-mortality binary outcome that would be observed under
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IV assignment z. Again, the non-mortality outcome would be measured after the
first time point, thus if the subject would die before that time point (S1i (z) = 0),
Yi (z) is not defined; otherwise S1i (z) = 1 and Yi (z) = 1 or 0, 1 indicating a worse
outcome. We further define S2i (z) to be the potential indicator of survival at the
second time point for subject i that would be observed if under IV assignment z. As
in section 2.2, if S1i (z) = 0, then S2i (z) = 0 by definition. We use Zi , Di , S1i , Yi and
S2i to denote respectively the observed IV, treatment received, observed survival
indicator at the first time point, observed non-mortality outcome and observed
survival indicator at the second time point for subject i.

2.4.1

Assumptions

We assume the following assumptions hold for the IV setup. These assumptions
combine those of Angrist, Imbens and Rubin (1996) for the IV setup and the ranked
average score with two stage survival information assumptions of section 2.2.
Assumption IV-1. Stable unit treatment value assumption (SUVTA).
• If zi = zi0 , then Di (z) = Di (z 0 ), S1i (z) = S1i (z 0 ), S2i (z) = S2i (z 0 ), and
Yi (z) = Yi (z 0 )
SUVTA means that a subject’s potential treatments and outcomes are not affected
by other individuals’ IV status and means that we can write Di (z) as Di (zi ), S1i (z)
as S1i (zi ), S2i (z) as S2i (zi ) and Yi (z) as Yi (zi )
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Assumption IV-2. Nonzero average causal effect of Z on D. The average causal
effect of Z on D, E[Di (1) − Di (0)], is not equal to zero.
Assumption IV-3. Independence of the instrument from unmeasured confounders:
the random vector (D(1), D(0), S1 (1), S1 (0), S2 (1), S2 (0), Y (1), Y (0)) is independent
of Z.
Based on subjects’ compliance behavior, we can first partition the population
into four groups:

Ui =






00, if Di (1) = Di (0) = 0









10, if Di (1) = 1, Di (0) = 0

(2.4.1)





11, if Di (1) = Di (0) = 1








01, if Di (1) = 0, Di (0) = 1
where 00, 10, 11, and 01 represent never taker, complier, always taker and defier,
respectively. Because Di (1) and Di (0) are never observed jointly, the compliance
behavior of a subject is unknown.
Assumption IV-4. Monotonicity of effect of IV on treatment: D(1) ≥ D(0).
There is no U=01 group.
Assumption IV-5. Monotonicity of effect of IV on survival: S1i (1) ≥ S1i (0),
S2i (1) ≥ S2i (0).
The monotonicity of the effect of the IV on the survival will hold if the treatment
never causes death and assumption IV-4 holds if the IV has a monotone effect on
treatment.
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Table 2.4: Principal Strata
Di (1) Di (0) S1i (1) S1i (0)

Principal Strata

1

0

1

1

Complier, always survivors

1

0

1

0

Complier, protected

1

0

0

0

Complier, never survivors

1

1

1

1

Never taker, always survivors

1

1

0

0

Never taker, never survivors

0

0

1

1

Always taker, always survivors

0

0

0

0

Always taker, never survivors

Assumption IV-6. Exclusion restrictions among never-takers and always-takers:
S1i (1) = S1i (0), S2i (1) = S2i (0), Yi (1) = Yi (0), for Ui = 00 or 11.
This means that the IV only affects the outcomes through treatment and has
no direct effect on outcomes.
Based on the possible joint combinations of (Di (1), Di (0), S1i (1), S1i (0)) under
the above assumptions, we can define principal strata as shown in Table 2.4.
Different from the case of randomized experiments with perfect compliance, the
principal strata in the IV setup are defined with respect to IV levels, for example,
the “complier, always survivors” are compliers(comply with their IV encouragement
of treatment) who would survive under both IV levels. Among all the principal
strata, the ”complier, always survivors” (1011) group is the only group that we
can observe the outcome under treatment if IV is 1, as well as the outcome under
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Table 2.5: Fine Strata
Probability

Di (1)

Di (0)

S1i (1)

S1i (0)

S2i (1)

S2i (0)

Principal Strata at Time Point 1

π101111

1

0

1

1

1

1

Complier, always survivors

π101110

1

0

1

1

1

0

Complier, always survivors

π101100

1

0

1

1

0

0

Complier, always survivors

π101010

1

0

1

0

1

0

Complier, protected

π101000

1

0

1

0

0

0

Complier, protected

π100000

1

0

0

0

0

0

Complier, never survivors

π111111

1

1

1

1

1

1

Always takers, always survivors

π111100

1

1

1

1

0

0

Always takers, always survivors

π110000

1

1

0

0

0

0

Always takers, never survivors

π001111

0

0

1

1

1

1

Never takers, always survivors

π001100

0

0

1

1

0

0

Never takers, always survivors

π000000

0

0

0

0

0

0

Never takers, never survivors

control if IV is 0, and that would survive under both treatment such that the nonmortality outcome Y is well defined in both cases. Thus, it is the only group for
which variation in the IV can identify the causal effect of the treatment on the
non-mortality outcome: CSACE = E(Yi (1) − Yi (0) | 1011).
Similarly to the case of randomized experiments with perfect compliance (Section 2.2), we can further incorporate the information of second time survival indicator to create finer strata as shown in Table 2.5.
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In terms of the fine strata in Table 2.5, the CSACE is expressed as:
CSACE = E(Yi (1) − Yi (0) | 1011)
= P (Yi (1) = 1 | 1011) − P (Yi (0) = 1 | 1011)
=

(π101111 E(Yi (1) | 101111) + π101110 E(Yi (1) | 101110) + π101100 E(Yi (1) | 101100))
π101111 + π101110 + π101100

−

(π101111 E(Yi (0) | 101111) + π101110 E(Yi (0) | 101110) + π101100 E(Yi (0) | 101100))
π101111 + π101110 + π101100
(2.4.2)

The same assumptions are made for compliers as we made for subjects under
randomized trials with perfect compliance (Assumptions 4-6 in Section 2.2).
Assumption IV-7. Among ”complier, always survivors”, the probability of worse
outcome for group 101111 is the lowest, whereas the probability of worse outcome
for group 101100 is the highest under both treatment arms:
P (Yi (1) = 1 | 101111) ≤ P (Yi (1) = 1 | 101110) ≤ P (Yi (1) = 1 | 101100)

(2.4.3)

P (Yi (0) = 1 | 101111) ≤ P (Yi (0) = 1 | 101110) ≤ P (Yi (0) = 1 | 101100)

(2.4.4)

Assumption IV-8. Among ”complier, protected”, the probability of worse outcome for group 101010 is no higher than that for group 101000 under treatment:
P (Yi (1) = 1 | 101010) ≤ P (Yi (1) = 1 | 101000)

(2.4.5)

Assumption IV-9. Under treatment, the probability of worse outcome for group
101100 is not lower than that for group 101010, but not higher than that for group
101000, and the probability of worse outcome for group 101110 is not higher than
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that for group 101010:
P (Yi (1) = 1 | 101110) ≤ P (Yi (1) = 1 | 101010) ≤ P (Yi (1) = 1 | 101100) ≤ P (Yi (1) = 1 | 101000)
(2.4.6)

2.4.2

Derivations of Bounds

As for the SACE in randomized experiments setup, the CSACE is not point identified without further assumptions based on the observable joint distribution of
(Zi , Di , S1i , S2i , Yi ), but can be bounded. We will again adopt the two step method
we used in section 2.3 to obtain the bound.
The observable strata of (Zi , Di , S1i , S2i ) are mixtures of fine strata, if we use
ps1 s2 d|z to denote P (S1i = s1 , S2i = s2 , Di = d | Zi = z), we have the following
identities:
p111|1 = π101111 + π101110 + π101010 + π111111

(2.4.7)

p101|1 = π101100 + π101000 + π111100

(2.4.8)

p001|1 = π100000 + π110000

(2.4.9)

p110|1 = π001111

(2.4.10)

p100|1 = π001100

(2.4.11)

p000|1 = π000000

(2.4.12)

p110|0 = π101111 + π001111

(2.4.13)

p100|0 = π101100 + π001100 + π101110

(2.4.14)
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p000|0 = π100000 + π000000 + π101010 + π101000

(2.4.15)

p111|0 = π111111

(2.4.16)

p101|0 = π111100

(2.4.17)

p001|0 = π110000

(2.4.18)

and the constraint
0 ≤ π101111 , π101110 , π101100 , π101010 , π101000 , π100000 , π111111 , π111100 , π110000 , π001111 , π001100 , π000000 ≤ 1
(2.4.19)

Given (2.4.7)-(2.4.18), we can express each π in terms of ps1 s2 d|z and π101100 :
π000000 = p000|1
π001111 = p110|1
π001100 = p100|1
π111111 = p111|0
π110000 = p001|0
π111100 = p101|0
π100000 = p001|1 − p001|0
π101111 = p110|0 − p110|1
π101000 = p101|1 − p101|0 − π101100
π101110 = p100|0 − p100|1 − π101100
π101010 = p111|1 + p110|1 + p100|1 − p110|0 − p100|0 − p111|0 + π101100
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and subject to the constraint of (2.4.19), we have,
max{0, p110|0 +p100|0 +p111|0 −p111|1 −p110|1 −p100|1 } ≤ π101100 ≤ min{p101|1 −p101|0 , p100|0 −p100|1 }
(2.4.20)

Bounds for the CSACE
For fixed π 0 s, let qys1 s2 d|z denote P (Yi = y, S1i = s1 , S2i = s2 , Di = d | Zi = z). We
have the following identities based upon the observable strata of (Yi , S1i , S2i , Di , Zi ):
q1111|1 = π101111 E(Yi (1) | 101111)+π101110 E(Yi (1) | 101110)+π101010 E(Yi (1) | 101010)+π111111 E(Yi (1) | 111111)
(2.4.21)
q1101|1 = π101100 E(Yi (1) | 101100) + π101000 E(Yi (1) | 101000) + π111100 E(Yi (1) | 111100)

(2.4.22)

q1110|1 = π001111 E(Yi (1) | 001111)

(2.4.23)

q1100|1 = π001100 E(Yi (1) | 001100)

(2.4.24)

q1111|0 = π111111 E(Yi (0) | 111111)

(2.4.25)

q1101|0 = π111100 E(Yi (0) | 111100)

(2.4.26)

q1110|0 = π101111 E(Yi (0) | 101111) + π001111 E(Yi (0) | 001111)

(2.4.27)

q1100|0 = π101110 E(Yi (0) | 101110) + π101100 E(Yi (0) | 101100) + π001100 E(Yi (0) | 001100)

(2.4.28)

Recall that
CSACE =

(π101111 E(Yi (1) | 101111) + π101110 E(Yi (1) | 101110) + π101100 E(Yi (1) | 101100))
π101111 + π101110 + π101100

−

(π101111 E(Yi (0) | 101111) + π101110 E(Yi (0) | 101110) + π101100 E(Yi (0) | 101100))
π101111 + π101110 + π101100
(2.4.29)

Given π 0 s,
(π101111 E(Yi (0)|101111)+π101110 E(Yi (0)|101110)+π101100 E(Yi (0)|101100))
π101111 +π101110 +π101100

=

q1110|0 +q1100|0 −q1110|1 −q1100|1
π101111 +π101110 +π101100

which is point identified. Thus to bound the CSACE, we only need to bound
π101111 E(Yi (1) | 101111) + π101110 E(Yi (1) | 101110) + π101100 E(Yi (1) | 101100), which
defines a linear programming problem:
min / max

(π101111 E(Yi (1) | 101111) + π101110 E(Yi (1) | 101110) + π101100 E(Yi (1) | 101100)) | π101100 (2.4.30)
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Subject to:

q1111|1 − q1111|0 = π101111 E(Yi (1) | 101111) + π101110 E(Yi (1) | 101110) + π101010 E(Yi (1) | 101010)

(2.4.31)

q1101|1 − q1101|0 = π101100 E(Yi (1) | 101100) + π101000 E(Yi (1) | 101000)

(2.4.32)

E(Yi (1) | 101111) ≤ E(Yi (1) | 101110) ≤ E(Yi (1) | 101100)

(2.4.33)

E(Yi (1) | 101010) ≤ E(Yi (1) | 101000)

(2.4.34)

E(Yi (1) | 101110) ≤ E(Yi (1) | 101010) ≤ E(Yi (1) | 101100) ≤ E(Yi (1) | 101000)

(2.4.35)

0 ≤ E(Yi (1) | 101111), E(Yi (1) | 101110), E(Yi (1) | 101100), E(Yi (1) | 101010), E(Yi (1) | 101000) ≤ 1

(2.4.36)

where constraints (2.4.33)-(2.4.35) are imposed by assumptions (IV-7) - (IV-9).
The above linear programming problem has a solution if and only if

q1101|1 −q1101|0
p101|1 −p101|0

≥

q1111|1 −q1111|0
.
p111|1 −p111|0

For each possible value of π101100 , we can solve the above linear programming
problem; then, combining this result with the bound for π101100 , let L = p110|0 +
p100|0 + p111|0 − p111|1 − p110|1 − p100|1 , U = min{p101|1 − p101|0 , p100|0 − p100|1 }, then
π101100 ∈ I, where I = [max{0, L}, U ], we obtain

max CSACE =

+

q1111|1 − q1111|0
p111|1 − p111|0

−

q1110|0 − q1110|1 + q1100|0 − q1100|1
p110|0 − p110|1 + p100|0 − p100|1

(q1101|1 − q1101|0 )(p111|1 − p111|0 ) − (q1111|1 − q1111|0 )(p101|1 − p101|0 )
(p101|1 − p101|0 )(p110|0 − p110|1 + p100|0 − p100|1 )(p111|1 − p111|0 )

·U

If L ≥ 0

min CSACE = max{

q1111|1 − q1111|0 + q1101|1 − q1101|0 − p111|1 + p111|0 − p101|1 + p101|0 + p110|0 − p110|1 + p100|0 − p100|1
p110|0 − p110|1 + p100|0 − p100|1

q1111|1 − q1111|0
p111|1 − p111|0

}−

,

q1110|0 − q1110|1 + q1100|0 − q1100|1
p110|0 − p110|1 + p100|0 − p100|1

If L < 0

min CSACE = max{

0} −

(q1111|1 − q1111|0 )(p101|1 − p101|0 ) + (q1101|1 − q1101|0 )(p110|0 − p110|1 + p100|0 − p100|1 − p111|1 + p111|0 )
,
(p101|1 − p101|0 )(p110|0 − p110|1 + p100|0 − p100|1 )

q1110|0 − q1110|1 + q1100|0 − q1100|1
p110|0 − p110|1 + p100|0 − p100|1
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2.5

Checking the plausibility of ranked average
score with two stage survival assumptions and
exclusion restriction assumptions

From the observable data, it cannot be determined whether our ranked average score
with two stage survival information assumptions for randomized experiments setup
or IV settings hold, also it cannot be determined whether the exclusion restriction
assumed in the IV settings hold. However, there are some necessary conditions that
the probability distribution of the observable data must satisfy when these assumptions are valid. If these conditions are violated, then we know our assumptions do
not hold.
For randomized experiments with perfect compliance, from the derivation of
the bound for SACE in section 2.3, we know that the linear programming problem
(2.3.14)-(2.3.20) under the ranked average score with two stage survival information
assumptions as well as the constraints imposed by the observable”infinite sample”
probability distribution has a solution if and only if
q111|1
q110|1
≥
p10|1
p11|1

(2.5.1)

This constraint says that the probability of the worse non-mortality outcome
among the patients that are randomly assigned to treatment and that survive to
the first time point but die before the second time point is equal to or larger than
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the probability of the worse non-mortality outcome among the patients that are
randomly assigned to treatment and that survive at least to the second time point.
This is a direct result from our ranked average score with two stage survival assumptions (Assumptions 4-6) which say that E(Yi (1) | 1111) ≤ E(Yi (1) | 1110) ≤
E(Yi (1) | 1010) ≤ E(Yi (1) | 1100) ≤ E(Yi (1) | 1000). The first three expectations
are for subjects who can survive at least to the second time point under treatment
and the last two expectations are for subjects who die before the second time point.
For the IV setting of Section 2.4, based on the calculations in section 2.4.2,
the corresponding necessary conditions that the probability distribution of the data
must satisfy under Assumptions (IV-1)-(IV-9) are as follows: ,
q1101|1 −q1101|0 ≥ 0, p101|1 −p101|0 ≥ 0, q1111|1 −q1111|0 ≥ 0, p111|1 −p111|0 ≥ 0 (2.5.2)

q1101|1 − q1101|0
q1111|1 − q1111|0
≥
p101|1 − p101|0
p111|1 − p111|0

(2.5.3)

Pearl (1995) provides a necessary condition on the joint probability distribution
of the outcome, treatment and IV when the exclusion restriction holds. Extending
Pearl’s result to our case where exclusion restrictions are assumed on both survival
at the first time point and the second time point as well as a non-mortality outcome
which may be censored, a necessary condition is that the following inequalities hold:

p00d|z1 + q010d|z2 + q110d|z3 + q011d|z4 + q111d|z5 ≤ 1
where d ∈ {0, 1}, zi ∈ {0, 1} for i = 1, 2, 3, 4, 5
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(2.5.4)

The above constraints to check the plausibility of our assumptions are for ”infinite sample” data. In practice, we can estimate the confidence with which the true
observable population distribution satisfies the above constraints using a simple
bootstrap procedure (Efron and Tibshirani, 1998). We bootstrap from the empirical
distribution of the observed data and then count the percentage of the bootstrapped
data sets for which the empirical distribution satisfies the constraints as an estimate
of the confidence. Efron and Tibshirani (1998) provide some refinements on this
simple bootstrap procedure that improve the accuracy of the estimated confidence.

2.6

Confidence Intervals for Bounds

In sections 2.3 and 2.4, the bounds we obtained are ”infinite sample” bounds where
we assume that the joint distributions of (Di , S1i , S2i , Yi ) or (Zi , Di , S1i , S2i , Yi ) is
known. However, in practice, all these probabilities need to be estimated from the
observed data. To account for the sampling uncertainty, we would like to construct
confidence intervals for the bounds. The simplest way to construct confidence interval is through the Bonferroni method, where if we want an overall level of 1 − α,
we can obtain first the individual 1 −

α
2

confidence interval for the upper bound

and lower bound (e.g., via the bootstrap), then combine the results to derive the
simultaneous confidence interval. The disadvantage of the Bonferroni method is it’s
conservative; the way to form it ignores the joint distribution of the upper bound
and lower bound. Horowitz and Manski (2000) proposed a method to obtain the
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confidence interval taking into account the joint distribution of the lower and upper bound. The Horowitz and Manski confidence interval adds the same length
to the upper and lower bounds in the confidence interval. Beran (1988) proposed
the B method which also takes into account the joint distribution of upper and
lower bounds without the restriction on the form of the confidence interval of the
Horowitz and Manski confidence interval. A description of the above confidence interval approaches for bounds can be found in Cheng and Small (2006). Because of
the nice properties of B method, we will use it to construct the confidence interval
for the ARDSNet study.
We did a simulation study to examine the finite sample coverage of the B method
95% confidence interval for data like the ARDSNet study (See Section 2.7). We simulated 2000 samples based on the observed empirical distribution of the ARDSNet
data (Table 2.6). Then for each simulated data set, we bootstrapped 2000 data sets
to obtain the 95% B method confidence interval. We counted the proportion of the
two thousand bootstrap CIs that cover the bound of the empirical distribution of
the ARDSNet data and did the analysis using both the two stage and one stage
assumptions. For the ranked average score with two stage survival information assumptions, the coverage probability of the B method is estimated to be 95.65%,
and for the ranked average score with one stage survival information assumptions,
the coverage probability of the B method is estimated to be 95.75%. Thus the finite
sample coverage of the B method for studies like the ARDSNet study seems to be
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good.

2.7

Application to ARDSNet Study

The ARDSNet study described in the introduction involved 861 patients with lung
injury and acute respiratory distress syndrome who were randomized to receive
mechanical ventilation with either lower tidal volumes or traditional tidal volumes.
The non-mortality outcome variable we are interested in is whether patients were
able to breathe without assistance by day 28 which is a measurement that reflects
the quality of life for patients after treatment. We use Yi to represent this binary
quality of life measurement, with Yi being 1 indicating that the ith patient were
not able to breathe without assistance by day 28. Naturally, the first survival time
point is day 28 after the treatment. If the patient died before day 28, then the
non-mortality outcome could not be measured, thus will be undefined. The second
time point survival indicator is whether the patient was eventually discharged home
with unassisted breathing or not. We view the patients who received mechanical
ventilation with lower tidal volume as the treatment group, and the patients who
received mechanical ventilation with traditional tidal volume as the control group.
Let Di equal 1 if the ith patient is randomized to treatment group, 0 if randomized
to control group. Further details on the data are described in appendix.
Table 2.6 presents the observed strata of (Di , S1i , S2i , Yi ). Among the survivors
in the lower tidal volume group, the proportion of patients that cannot breathe
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Table 2.6: Observed data for ARDSNet Study
Number of Patients

Di

S1i

S2i

Yi

258

1

1

1

0

29

1

1

1

1

10

1

1

0

0

26

1

1

0

1

109

1

0

0

–

211

0

1

1

0

34

0

1

1

1

7

0

1

0

0

25

0

1

0

1

152

0

0

0

–
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Table 2.7: The estimated bounds and 95% B method CIs of the SACE for ARDSNet
study using ranked average score with two stage survival assumptions and one stage
survival assumptions.
SACE

Two-stage survival assumptions

One-stage survival assumptions

Estimated bounds

[−12.99%, −4.02%]

[−17.38%, −4.27%]

95% confidence interval

[−20.11%, 1.99%]

[−27.57%, 2.18%]

without assistance by day 28 is 17.03% (which is 55/323); among the survivors in
the traditional tidal volume group, the proportion of patients that cannot breathe
without assistance by day 28 is 21.30% (which is 59/277). The difference of those
two proportions −4.27% which is a direct comparison of the QOL among survivors
in the lower tidal volume and survivors in the traditional tidal volume is likely an
upward biased estimate for the SACE due to the informativeness of censoring by
death.
The empirical distribution of (Di , S1i , S2i , Yi ) satisfies the constraint (2.5.1). Using the bootstrap procedure, all of the 2000 bootstrapped datasets satisfy the constraint (2.5.1), thus we are very confident that our set of two stage assumptions is
plausible in the sense that it does not violate the constraint (2.5.1).
Table 2.7 compares the estimated bounds of the SACE as well as the 95% confidence intervals obtained through our proposed ranked average score with two stage
survival information assumptions to the ranked average score with one stage survival
information assumptions. According to the result of our two stage analysis, among
the patients with lung injury and the acute respiratory distress syndrome who would
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survive under both ventilation tidal volumes, the lower tidal volume would help reduce the probability of breathing with assistance by day 28 by an amount between
4.02% to 12.99%. This bound for the SACE is substantially shorter, thus more
informative, than the bound obtained through the one stage analysis which estimates the reduction to be between [4.27%, 17.38%]. The 95% B method confidence
intervals under both sets of assumptions cover 0, meaning that there is not strong
evidence that ventilation with lower tidal benefits patients in terms of the quality
of life outcome of breathing without assistance by day 28.

2.8

Conclusions and Discussions

The effect of treatment on a non-mortality outcome among always survivors is of
interest in many clinical studies. The previous literature on bounding the SACE
uses only the survival information before the measurement of the non-mortality
outcome; however, in many cases, the survival information after the measurement
of non-mortality outcome is informative. We proposed a set of ranked average score
with two stage survival information assumptions which are plausibly satisfied in
many quality of life studies and developed a two-step linear programming approach
to obtain the closed form of the bounds of the SACE under our assumptions. Our
method works not only for randomized trials with perfect compliance, but also can
be extended to randomized trials with noncompliance or observational studies with
a valid IV to obtain bounds on the complier survivor average causal effect.
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We applied our method to the ARDSNet study. Making use of the post QOL
measurement survival information (patients’ status when discharged home) in addition to the pre-QOL survival information (survival status at day 28) helps substantially shorten the bound on the SACE – the effect of lower tidal volume on being
able to breathe without assistance by day 28.
The SACE and CSACE are principal strata effects, causal effects on a subgroup
of patients defined by the values that post-randomization variables would take under both treatment and control (Frangakis and Rubin, 2002). We have shown that
bounds on these principal strata effects can be sharpened by using the further outcome information of survival after the non-mortality outcome is measured. In a
different context, Mealli and Pacini (2013) showed that using further outcomes can
narrow bounds on principal strata effects. Mealli and Pacini consider an outcome
that is not affected by censoring by death in a randomized trial with noncompliance, and study bounds on the intention to treat effects for the compliers, always
takers and never takers. Mealli and Pacini consider settings in which the exclusion restriction may not be satisfied and they show that a secondary outcome for
which the exclusion restriction is satisfied can be used to narrow the bounds. For
randomized trials with noncompliance in which there is censoring by death and the
exclusion restriction may not be satisfied, it would be of future research interest
to consider combining the post-quality of life measurement survival information we
have studied with the secondary outcomes Mealli and Pacini studied to narrow the
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bounds on the CSACE.
So far, we have assumed that we are in the context of a randomized trial or an
observational study with a valid IV. Our method can also be naturally extended to
the cases in which conditional on some discrete covariates there is ignorability such
that the subjects are randomized or the IV is valid conditional on the covariates.
We can stratify the subjects into subsets defined by each level of covariates, and
apply our method to obtain the bound of SACE within each subgroup. Then we
can obtain the overall bound of SACE combining the proportions of each subgroup.
See (Freiman and Small, 2013) for more details on this topic. How to deal with the
case in which the covariates are continuous requires further research.
In this study, we focus on studies where the non-mortality outcome is measured
at a fixed time for all subject. However, there are cases where the non-mortality outcome might be measured at different time for different subjects which complicates
the analysis. For instance, IVH may happen at any time in the first several days
of life of babies. How to handle the situation in which the non-mortality outcome
could be measured at continuous time period is a topic we are working on.
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Chapter 3
IV with Nonignorable Missing
Covariates

3.1
3.1.1

Introduction
Effect of type of delivery NICUs on premature infants

Premature infants are infants born before a gestational age of 37 complete weeks.
Compared to term infants, premature infants have less time to develop, so that they
are at higher risk of death and complications and often in need of advanced care, ideally in a neonatal intensive care unit (NICU) (Profit et al., 2010; Doyle et al., 2004;
Boyle et al., 1983). There are two types of NICUs - a high level NICU is a NICU
that has the capacity for sustained mechanical assisted ventilation and that delivers
on average of at least 50 premature babies per year, whereas a low level NICU is
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a unit that does not meet these requirements. There is literature that shows that
delivery at high level vs. low level NICUs is associated with a reduction in neonatal
mortality after controlling for measured confounders (Phibbs et al., 2007; Chung
et al., 2010; Rogowski et al., 2004). However, there are unmeasured confounders
such as fetal heart tracing test results and severity of conditions that could bias
these results. The aim of this chapter is to use the instrumental variable method
along with a novel method of controlling for nonignorable missing covariates to obtain unbiased inferences about the effect on neonatal mortality of premature babies
being delivered in a high level NICU vs. a low level NICU. Understanding how
effective high level NICUs are compared to low level NICUs is important for both
individual mothers deciding whether to travel a distance to go to a high level NICU
rather than going to a local low level NICU, and also for public policy decisions
about premature infant care. In the 1970s, a system of perinatal regionalization
was built in most states in which most infants at risk of complications such as very
premature infants would be sent to regional high level NICUs (Lasswell et al., 2010).
This regionalization system has weakened in recent years with more very premature
infants being born in low level NICUs (Lasswell et al., 2010; Howell et al., 2002;
Richardson et al., 1995; Yeast et al.,1998). If high level NICUs are truly providing
considerably better care for premature babies, then it is valuable to invest resources
in strengthening the perinatal regionalization system, while if high level NICUs are
providing at best marginal improvements in care, then strengthening the perinatal

49

regionalization should probably not be a priority. Additionally, if only certain types
of premature babies benefit from high level NICUs (e.g., only those below a certain
gestational age), then resources would be best spent on increasing the rate of high
level NICU delivery for those types of babies. To address this, we will estimate the
effect of high level NICU delivery for babies with different characteristics, such as
different gestational ages.
The ideal way to assess the effectiveness of high level NICUs vs. low level NICUs
would be to randomize pregnant women to deliver at different level NICUs, but
such a study is not ethical or practical. We instead consider an observational study.
We have compiled data on all babies born prematurely in Pennsylvania between
1995-2005 by linking birth certificates to death certificates as well as maternal and
newborn hospital records. More than 98% of the birth certificates could be linked
to the hospital records (Lorch et al. (2012) for more details). We will use the
189,991 records that could be linked in our analysis. The measured confounders we
will consider are gestational age, the month of pregnancy that prenatal care started
(precare), and mother’s education level. If these measured confounders are the only
confounding variables, i.e., the only variables that are related to both level of NICU
delivered at and mortality, then we could use propensity score/matching/regression
methods to control for the confounders. Unfortunately, some key confounders are
unmeasured such as the results of tests like fetal heart tracing which are related to
both how strongly a doctor encourages a woman to deliver at a high level NICU
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and a baby’s risk of mortality. To control for such unmeasured confounders, we will
consider the instrumental variable (IV) method.

3.1.2

Instrumental variable approach

The IV method is widely used in observational studies (Angrist and Krueger, 1991;
Baiocchi et al., 2010). An instrumental variable (IV) is a variable that is (i) associated with the treatment, (ii) has no direct effect on the outcome, and (iii) is
independent of unmeasured confounders conditional on measured confounders. The
relationships between the IV, treatment(D), outcome(Y), measured confounders
(X) and unmeasured confounders(U C) are shown in the directed acyclic graph in
Figure 1. The basic idea of the IV method is to extract variation in the treatment
that is free of the unmeasured confounders and use this confounder free variation to
estimate the causal effect of the treatment on the outcome. The beauty of the IV
method is that although treatment is not randomly assigned in observational studies, the method still allows consistent estimation of the causal effect of a treatment.

X
IV k

v

× }
/D
a


/+ Y
O

×

UC
Figure 1. This directed acyclic graph shows the assumptions for a valid IV. D denotes the
treatment, Y the outcome, X measured confounders and UC unmeasured confounders.
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The key assumptions for an IV are (i) the IV affects D; (ii) the IV does not have a direct
effect on Y; (iii) the IV is independent of the unmeasured confounders UC given the
measured confounders.

The instrumental variable we consider is whether or not the excess travel time
that a mother lives from the nearest high level NICU compared to the nearest low
level NICU is less than or equal to 10 minutes; a mother is said to live ”near” to
a high level NICU if the excess travel time is ≤ 10 minutes and ”far” otherwise.
Excess travel time satisfies the first two characteristics of an IV: (i) association
with treatment: previous studies suggest that women tend to deliver at NICUs
near their residential zip code (Lorch et al., 2012; Phibbs et al., 1993) and (ii)
no direct effect: most women have time to deliver at both the nearest high level or
other delivery NICU so the marginal travel time to either facility should not directly
affect outcomes (Lorch et al., 2012). The third assumption needed for excess travel
time to be an IV, that it is independent of unmeasured confounders conditional on
measured confounders, is plausible in that most women do not expect to have a
premature delivery and hence do not choose where to live based on distance to a
high level NICU. However, because high level NICUs tend to be in certain types
of places (e.g. in cities) and people living in places with high level NICUs have
different characteristics from people living far away from high level NICUs, for the
third IV assumption to hold, we need to condition on these characteristics that may
affect the risk of neonatal death in these pregnancies. The measured characteristics
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we are able to condition on are the month of pregnancy that prenatal care started
(precare), mother’s education, and gestational age of the baby. We only have a small
number of measured characteristics; for settings where there are a large numbers
of measured characteristics, it is worth considering Lasso methods to control for
the characteristics as in Imai and Ratkovic (2012). In previous work (Guo et al.,
2014; Lorch et al., 2012), we used excess travel time as an IV to estimate the
effect of high level vs. low level NICUs, but we did not account for the potential
nonignorable missingness of certain measured characteristics. We will develop a
method for accounting for nonignorable missing covariates.

3.1.3

Nonignorable missing covariates

Among the measured confounders, the gestational ages are completely recorded
but some subjects’ precare and education level are missing . We are concerned
that the missingness is related with the outcome (death) and the risks of mother
and infant. The information for mother is usually filled out partly by mother, and
partly by the nurse or doctor. If the baby died, the mother may not want to fill
out the questionnaire due to her grief, or nurses may not bother the mother to
fill out a questionnaire out of caring for the mother’s grief. When the mother or
infant is at high risk of complications, nurses and doctors focus on this emergency
and may ignore recording mother’s information. Consequently, missingness is only
plausibly ignorable if we condition on the outcome (death) and mother’s/infant’s
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risk of complications. The outcome is fully observed but the mother’s/infant’s risk
of complication is not fully observed. The measured variable gestational age is a
strong predictor of risk but other predictors of risk that are known to the doctor but
not recorded in the data include the results of fetal heart tracing and the doctor’s
knowledge about the severity of mother’s and baby’s condition. These unmeasured
confounders may be related to the compliance status of the mother. The compliance
status of the mother refers to whether the mother would deliver at a high level NICU
if she lived near to one (excess travel time ≤ 10 minutes) and whether she would
deliver at a high level NICU if she lived far from one (see section 3.2.2 for further
discussion). If the mother would always deliver at a high level NICU regardless of
whether she lives near to one, her compliance status is always taker. If the mother
would only deliver at a high level NICU if she lives near one, her compliance status
is complier. If a doctor knows that a baby/mother is at higher risk of complications
based on fetal heart tracing or other knowledge, then the doctor is more likely
to recommend the mother to deliver at a high level NICU regardless of how near
she lives to the high level NICU and the mother is more likely to be an always
taker. Thus, compliance status is related to unmeasured risk and consequently,
the missingness of observed variables is likely to be related to compliance status.
Compliance status is only partially observed, e.g., under the assumptions in section
3.2.2, if a mother lives far from a high level NICU, but still delivers at a high level
NICU, she is an always taker, but if she lives near a high level NICU and delivers
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at a high level NICU, she might be an always taker or complier.
Previous literature on IV with missing data has considered missing outcomes
(Frangakis and Rubin, 1999; Levy, O’Malley and Normand, 2004; Mealli et al.,
2004; Peng, Little and Raghunathan, 2004; Chen, Geng and Zhou, 2009; Small
and Cheng, 2009). In this literature, it has been argued that ignorability of the
missing outcome may only be plausible after conditioning on the covariates and the
partially observed compliance status (see (3.2.1)). Methods have been developed
for estimating causal effects under this ”latent ignorability”. For missing covariates
rather than missing outcomes, the only work on IV estimation that we are aware of
is Peng, Little and Raghunathan (2004), which assumes missingness of covariates is
ignorable conditional on observed data, but not allowed to depend on compliance
behavior. In this chapter, we develop a method for estimation of the causal effect
when the missingness of covariates may depend on the fully observed data as well
as the partially observed compliance behavior.
Generally, if missingness depends only on observed variables, even on observed
outcome, methods like multiple imputation under the assumption that the data is
missing at random (MAR) can provide reasonably good estimates (Schafer, 1997).
However, if the missingness of covariates also depends on partially observed compliance status, multiple imputation methods based on MAR assumptions may fail
to provide valid inference. In this chapter, we will provide a model which allows
for missingness to depend on partially observed compliance status and we use the
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EM algorithm to obtain the MLE estimates. We also provide a sensitivity analysis
which allows for missingness to depend on further unobserved confounders besides
compliance status.
Many other observational studies face similar issues of unmeasured confounding
and missing data as ours, and the methods we develop in this paper may be useful for
them. For example, for studying the comparative effectiveness of two types of drugs,
data collected as part of routine health care practice is often used. Such data may
not contain measurements of important prognostic variables that guide treatment
decisions such as lab values (e.g., cholesterol), clinical variables (e.g., weight, blood
pressure), aspects of lifestyle (e.g., smoking status, eating habits) and measures
of cognitive and physical functioning (Walker, 1996; Brookhart and Schneeweiss,
2007). To control for such unmeasured confounders, instrumental variable methods
have been used, for example, the prescribing preference of a patient’s physician
for one type of drug vs. the other has been used as an IV (Korn and Baumrind,
1998; Brookhart et al., 2006). For prescribing preference to be a valid IV, it is
often necessary to condition on patient characteristics that differ between different
physicians to account for the possibility that certain physicians tend to see sicker
patients and these physicians may be more likely to prefer one type of drug than
physicians who tend to see less sick patients (Korn and Baumrind, 1998). However,
there is often missing data on some of these patient characteristics we would like to
condition on, in particular because the data is collected as part of routine practice
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rather than as part of a research study. For example, even if lab tests are always
measured when a lab test is actually administered, since doctors will only order a
lab test for some patients, there will be missing data. The missingness of lab values
might be related to the treatment decision and outcome, and be nonignorable. For
example, the decision to order a lab test is likely related to patient symptoms and/or
disease severity, and we would expect that the probability of a lab test being ordered
depends on what the value of the test would be, if measured, with unusual values
being more likely to be measured (Roy and Hennessy, 2011). Thus, comparative
effectiveness studies of drugs may need to consider instrumental variable methods
with nonignorable missing covariates as in our study.

3.2
3.2.1

Notation and Assumptions
Notation

We use the potential outcome approach to define causal effects. Let Zi represent
the binary IV of infant i; 1 if excess travel time is less than 10 minutes, which
encourages delivery in a high level NICU; 0 if excess travel time is more than 10
minutes, which does not provide encouragement of delivery in a high level NICU.
In our data, 56.4% of subjects have excess travel time less than 10 minutes. We
use Z to denote the vector of IVs for all infants. Let Di (z) be the potential binary
treatment variable that would be observed for subject i under IV assignment z. Let
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Di (z) be 1 if baby i would be delivered at a high level NICU under the vector of z
and 0 if the baby would be delivered at a low level NICU. We also let Yi (z) denote
the potential binary outcome, neonatal death indicator, that would be observed for
infant i under IV assignment z, with Yi (z) being 1 indicating that the newborn
would die in the hospital (neonatal death). We use X i to denote the covariate
values for ith subject. The covariates in our study are discrete: infant’s gestational
weeks, the month of pregnancy that prenatal care started and mother’s education,
namely 8th grade or less, some high school, high school graduate, some college,
college graduate, and more than college. For simplicity, we include the intercept
in X i . Finally, we let Rix (z) be the binary response indicator of covariate x under
IV z, that is, Rix (z) = 1 if covariate x would be observed for infant i under IV
assignment z, and Rix (z) = 0 if covariate x would be missing. There is a Rix (z)
for each covariate. In the above set of notations, Di (z), Yi (z) and Rix (z) are all
potential outcomes of an infant. For each infant, depending on the value of z, one
scenario is factual (observed), the other ones are counter factual (not observed). We
use Di , Yi and Rix to denote observed treatment received, observed death outcome
of infant, and the observed response indicator for covariate x.

3.2.2

Assumptions

We assume the following assumptions hold in our study. The first 5 assumptions
are the same as Angrist, Imbens and Rubin (1996).
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Assumption 1. Stable unit treatment value assumption (SUVTA) , meaning
that a subject’s potential outcomes cannot be affected by other individuals’ status.
SUVTA allows us to write Di (z) as Di (zi ), Yi (z) as Yi (zi ) and Rix (z)=Rix (zi ).
This assumption is plausibly satisfied for our data since whether a mother delivers
at a high level NICU and her baby’s outcome is unlikely to be affected by other
mothers’ choice of living near to a high level NICU or not.
Based on subjects’ compliance behavior, we can partition the population into
four groups:

Ui =






n, if Di (1) = Di (0) = 0









c, if Di (1) = 1, Di (0) = 0




a,









d,

(3.2.1)

if Di (1) = Di (0) = 1
if Di (1) = 0, Di (0) = 1

where n, c, a, and d represent never taker, complier, always taker and defier, respectively. Because Di (1) and Di (0) are never observed jointly, the compliance behavior
of a subject is unknown. The parameter of interest in our study is the complier
average causal effect (CACE), E(Yi (1) − Yi (0) | Ui = c, Xi = x).

Assumption 2. Nonzero average causal effect of Z on D. The average causal
effect of Z on D, E[Di (1) − Di (0)], is not equal to zero.
The excess travel time should affect whether mother delivers at a high level or
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low level NICU due to near NICUs being more convenient, thus assumption 2 is
plausible.

Assumption 3. Independence of the instrument from unmeasured confounders:
conditional on X, the random vector (Y(0), Y(1), D(0), D(1)) is independent of Z.
This assumption is plausible for our study because premature delivery is unexpected for women, so people do not choose where to live based on the closeness to
high level NICU, especially after controlling for measured socioeconomic variable
such as mother’s education level.

Assumption 4. Monotonicity: D(1) ≥ D(0).
If a mother is willing to travel to deliver at a high level NICU when living 10 or
more minutes further to a high level NICU than a low level NICU, she is probably
also willing to travel to deliver at a high level NICU when living less than 10 minutes further to a high level NICU than a low level NICU.

Assumption 5. Exclusion restrictions among never-takers and always-takers:
Yi (1) = Yi (0) if Ui = n, and Yi (1) = Yi (0) if Ui = a.
This means that the IV only affects the outcome through treatment and has no
direct effect. In our study, this is plausible because most women have enough time
to make it to either the nearest high level or low level NICU so that marginal travel
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time should not directly affect outcomes.

Assumption 6. Nonignorable missingness assumption (missingness ignorable
conditional on compliance class, outcome and fully observed covariates): suppose
the first k covariates of X are fully observed, and the last m-k covariates have missing values, then,
Xi,j

P (Ri

Xi,j

(z) | Yi (z), Ui , X i ) = P (Ri

(z) | Yi (z), Ui , Xi,1 , ..., Xi,k ), ∀j = k + 1, ..., m.

This is saying that the missingness of covariates precare and mother’s education
depends only on neonatal death information, compliance status of infant, gestational
age (fully recorded) as well as the delivery level of NICU. It’s a plausible assumption
for our data given the discussion in section 3.1.3.
Assumption 7. Exclusion restriction on missing indicator among never-takers
Xi,j

and always-takers. Ri

Xi,j

(1) = Ri

Xi,j

(0) if Ui = n, and Ri

Xi,j

(1) = Ri

(0) if Ui = a.

These are analogous assumptions to Frangakis and Rubin (1999). This means
that the IV has no effect on missingness for never takers and always takers. We
think this assumption is plausible for our data for the following reasons. We think
that the missingness of covariates if affected by death and the baby’s risk of death
and complications as captured by gestational age and compliance class. Since for
always takers and never takers, death is not affected by their level of the IV z ( this
is assumption 5), and additionally the gestational age and compliance class are not
affected by the level of the IV, the missingness of covariates for always takers and
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never takers should not be affected by the level of the IV.

3.3

Model and Estimation

We use a general location model (Olkin and Tate, 1961; Little and Rubin, 2002) for
a mixture of continuous and categorical covariate variables, which could be easily
adjusted for cases where covariates variables are all categorical or all continuous.
We consider logistic models for (i) treatment assignment given covariates, (ii) outcome in each compliance class/ treatment assignment combination given covariates,
and (iii) missingness in each compliance class/treatment assignment combination
given covariates, and we use a multinomial logistic model for compliance class.

Model for covariate : Suppose that in the m covariates, the first p are categorical
and the remaining m-p are continuous. We assign probability Wx1 ,...,xp to each
combination of possible values of those p categorical covariates variables, where
Wx1 ,...,xp are unknown parameters, and sum up to 1.
• (Xi,1 , ..., Xi,p ) are iid distributed with
P ((Xi,1 , ..., Xi,p ) = (x1 , ..., xp )) = Wx1 ,...,xp , where

X

Wx1 ,...,xp = 1 (3.3.1)

• Conditional on (Xi,1 , ..., Xi,p ) = (x1 , ..., xp ), we assume that the continuous
covariates random variables (Xi,p+1 , ..., Xi,m ) is multivariate normal with unknown mean vector µx1 ,...,xp which may depend on the values of (x1 , ..., xp ),
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and with unknown common positive definite covariance matrix Σ in order to
reduce the number of parameters.
Xi,p+1 , ..., Xi,m | (Xi,1 , ..., Xi,p ) = (x1 , ..., xp ) ∼iid Nm−p (µx1 ,...,xp , Σ)

(3.3.2)

Model for IV :
P (Zi = 1 | X i = x) =

exp (αT x)
1 + exp (αT x)

(3.3.3)

Model for compliance class :
P (Ui = n | X i = x) =

1
1+

exp (δaT x)

+ exp (δcT x)

(3.3.4)

P (Ui = c | X i = x) =

exp (δcT x)
1 + exp (δaT x) + exp (δcT x)

(3.3.5)

P (Ui = a | X i = x) =

exp (δaT x)
1 + exp (δaT x) + exp (δcT x)

(3.3.6)

Model for outcome :
P (Yi (z) = 1 | Ui = u, X i = x) =

T
x)
exp (βuz
T x)
1 + exp (βuz

(3.3.7)

According to assumption 4, βa0 = βa1 , and βn0 = βn1 . The quantity of interest is
the average treatment effect for compliers of each covariate level, which is estimated
by E(Y (1) − Y (0) | U = c, X = x) =

1
T x)
1+exp (βc0

−

1
T x) .
1+exp (βc1

Model for missingness indicators :
Xi,j

P (Ri

(z) = 1 | Yi (z) = y, Ui = u, X i,1,...,k = x1,...,k ) =

T x
exp (θj,u
1,...,k + γj,u Iy=1 + ηj,u Iz=1 )
T x
1 + exp (θj,u
1,...,k + γj,u Iy=1 + ηj,u Iz=1 )

(3.3.8)

where j = k + 1, ..., m. Based on assumption 7, ηj,a = ηj,n = 0, ∀j = k + 1, ..., m
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Under the model (3.3.1)-(3.3.8), we seek to maximize the likelihood of the joint
distribution of X, Z, U, Y, R. If we know the compliance classes and the missing
covariates for each subject, we can get the MLE of parameters involved in those
models easily. Based on this idea, we are going to use EM algorithm.

3.3.1

EM algorithm

For simplicity, we are going to present the EM algorithm for the case where all
the covariates are categorical and that there are 4 covariates (including intercept)
with only the first two completely observed, which is the case of our data. The
EM algorithm can be easily extended to other scenarios. The first covariate is
the intercept, and we further assume that the other three covariates are ordered
categorical with q2 , q3 , q4 levels respectively. For a nominal categorical variable, we
can use indicator functions for each category, which the following algorithm could
be easily adjusted for.
Let Nr3 ,r4 ,x2 ,x3 ,x4 ,u,z,y be the number of cases where RiX3 = r3 , RiX4 = r4 , Xi,2 =
x2 , Xi,3 = x3 , Xi,4 = x4 , Zi = z, Yi = y, Ui = u. Notice that Xi,1 = 1, ∀i. Those
numbers are only partially observed, however, if they are known, the complete data
log likelihood is,
lc

=

X

Nr3 ,r4 ,x2 ,x3 ,x4 ,u,z,y · (log(Wx2 ,x3 ,x4 ) + log(P (Zi = z | Xi = (1, x2 , x3 , x4 )))

r3 ,r4 ,x2 ,x3 ,x4 ,u,z,y

+ log(P (Ui = u | Xi = (1, x2 , x3 , x4 ))) + log(P (Yi = y | Zi = z, Ui = u, Xi = (1, x2 , x3 , x4 )))
Xi,3

= r3 | Zi = z, Yi = y, Ui = u, Xi,2 = x2 ))

Xi,4

= r4 | Zi = z, Yi = y, Ui = u, Xi,2 = x2 )))

+ log(P (Ri

+ log(P (Ri
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Once we know N, the MLE estimates of the logistic models in (3.3.3)-(3.3.8) are
standard, and the MLE for Wx2 ,x3 ,x4 ∝ N,,x2 ,x3 ,x4 ,,, , where N,,x2 ,x3 ,x4 ,,, is defined to
be

P

r3 ,r4 ,u,z,y

Nr3 ,r4 ,x2 ,x3 ,x4 ,u,z,y .

In the E-step, conditional on observed data and parameters’ estimates obtained
through the previous step, we can get the expected values for Nr3 ,r4 ,x2 ,x3 ,x4 ,u,z,y .
From the observed data, we can get the following counts:
1. N Nx2 ,x3 ,x4 ,d,z,y which denotes the number of cases that Xi,3 , Xi,4 are both
observed and that Xi,2 = x2 , Xi,3 = x3 , Xi,4 = x4 , Di = d, Zi = z, Yi = y
2. N 3x2 ,x4 ,d,z,y which denotes the number of cases that only Xi,3 are unobserved
and that Xi,2 = x2 , Xi,4 = x4 , Di = d, Zi = z, Yi = y
3. N 4x2 ,x3 ,d,z,y which denotes the number of cases that only Xi,4 are unobserved
and that Xi,2 = x2 , Xi,3 = x3 , Di = d, Zi = z, Yi = y
4. N Bx2 ,d,z,y which denotes the number of cases that Xi,3 , Xi,4 are both missing
and that Xi,2 = x2 , Di = d, Zi = z, Yi = y
Further, let Pr3 ,r4 ,x2 ,x3 ,x4 ,u,z,y be the probability of a subject having case where RiX3 =
r3 , RiX4 = r4 , Xi,2 = x2 , Xi,3 = x3 , Xi,4 = x4 , Zi = z, Yi = y, Ui = u which are
calculated based on models (3.3.1)-(3.3.8). Then we can get the expected values for
each Nr3 ,r4 ,x2 ,x3 ,x4 ,u,z,y , for example,
EN1,1,x2 ,x3 ,x4 ,a,1,y = N Nx2 ,x3 ,x4 ,1,1,y

P1,1,x2 ,x3 ,x4 ,a,1,y
P1,1,x2 ,x3 ,x4 ,a,1,y + P1,1,x2 ,x3 ,x4 ,c,1,y
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To save space, all the formulas to update each Nr3 ,r4 ,x2 ,x3 ,x4 ,u,z,y are given in
appendix. By iteratively finding the E step estimate of N and maximizing the
expected value of the complete data log likelihood in the M step until the algorithm
converges, we obtain estimates of the parameters in models (3.3.1)-(3.3.8).

3.4

Simulation

In this section, we conduct simulation studies to estimate the complier average
causal effect in the simplest context where there is only one covariate, the values of
which could only be 0,1. We consider the following three scenarios under assumptions 1-7: 1) covariate is missing completely at random; 2) covariate is missing at
random, meaning that the missingness does not depend upon the unobserved data,
for example, does not depend on latent compliance status ; 3) missing mechanism
for covariate is nonignorable: the missingness of covariate can depend on not only
the observed outcome Y, treatment assignment Z, but also latent compliance status
U.
In each scenario, we are going to apply the following three estimation methods and compare their results: 1) complete case analysis, which provides unbiased
estimates when the missing mechanism of the data is missing completely at random. 2) the estimates using multiple imputation by chained equations (conducted
by MICE, see Van Buuren and Groothuis-Oudshoorn, 2011) which gives valid estimates when data are missing at random. 3) Our method, which is designed to deal
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with nonignorable missingness of covariates.
In the single covariate case, the models described in section 3 can be represented
simply by the following set of parameters: Wu , which is P (Ui = u); Mu , which is
P (Xi = 1 | Ui = u); ξx , which represents P (Zi = 1 | Xi = x); θzux , which denotes
P (Yi (z) = 1 | Ui = u, Xi = x) and ρyzu , which are parameters for missingness
indicators P (Ri (z) = 1 | Yi = y, Ui = u), where Ri = 0 if covariate for ith subject
is missing. θ1c1 − θ0c1 and θ1c0 − θ0c0 are corresponding compliers’ average causal
effect for subjects with X being 1 and 0 respectively.
In all three scenarios, the parameters other than the ones in the missingness
model are arbitrarily chosen and fixed as follows:

Wn = 0.2, Wa = 0.375, Mn = 0.5, Ma = 0.25, Mc = 0.8, ξ1 = 0.4, ξ0 = 0.6
θ1n1 = 0.5, θ1n0 = 0.3, θ0a1 = 0.8, θ0a0 = 0.7
θ1c1 = 0.7, θ1c0 = 0.45, θ0c1 = 0.45, θ0c0 = 0.3
The missingness parameters in each scenario are described below, the values for
ρ0 s are chosen to generate 12% missingness for covariate (the same missing rate
as in the NICU study), and satisfy the exclusion restriction for missing indicator,
which implies that ρy0a = ρy1a , and ρy0n = ρy1n . In the first case, the missingness
parameters ρ0 s are the same for all possible outcomes, IV levels as well as compliance
classes, thus the covariate is missing completely at random; in the second case, the
missing rates are different for different outcomes and IV levels, however won’t be
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affected by partially observed compliance status, so that the missingness won’t
depend on unobserved data, which is a case of missing at random; in the last case,
besides outcome and IV, the compliance status also plays a role in deciding the
probability of missingness, and the values of ρ0 s are chosen so that even the largest
effect of compliance status on missingness is still moderate (ρ11a − ρ11n = 0.25) and
realistic.
1. Missing Completely at Random

ρ11n = ρ01n = ρ10a = ρ00a = ρ11c = ρ01c = ρ00c = ρ10c = 0.88

2. Missing at Random

ρ11n = ρ10n = ρ10c = 0.88, ρ10a = ρ11a = ρ11c = 0.78
ρ01n = ρ00n = ρ00c = 0.94, ρ00a = ρ01a = ρ01c = 0.97
3. Nonignorable Missingness

ρ11n = ρ10n = 0.75, ρ01n = ρ00n = 0.8, ρ10a = ρ11a = 1
ρ00a = ρ01a = 0.95, ρ11c = 0.8, ρ01c = 0.9, ρ00c = 0.83, ρ10c = 0.97
We simulated 500 data sets for each scenario described above with each simulated
dataset containing 5000 subjects. Under the above setup, the CACE for subjects
with covariate being 1 is 0.25, whereas the CACE for subjects with covariate 0 is
0.15. Table 3.1 shows the means and standard deviations for the estimates of CACE
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across 500 simulated datasets using the EM algorithm based on our nonignorable
missingness assumption, the complete-case estimates and multiple imputation estimates using MICE for each missingness mechanism. The corresponding bias in
percentage is given in parentheses.
Table 3.1: Simulation Results under MCAR, MAR and Nonignorable Missing Mechanism
MCAR

MAR

Nonignorable

CACE

EM(NI)

Complete-Case

MICE

Mean

SD

Mean

SD

Mean

SD

θ1n1 − θ0n1 =0.250

0.250 (0.00%)

0.027

0.249 (0.40%)

0.028

0.248 (0.80%)

0.028

θ1n0 − θ0n0 =0.150

0.149 (0.67%)

0.095

0.148 (1.33%)

0.096

0.154 (2.67%)

0.095

CACE

EM(NI)

Complete-Case

MICE

Mean

SD

Mean

SD

Mean

SD

θ1n1 − θ0n1 =0.250

0.250 (0.00%)

0.027

0.221 (11.60%)

0.029

0.246 (1.60%)

0.028

θ1n0 − θ0n0 =0.150

0.147 (2.00%)

0.097

0.113 (24.67%)

0.096

0.160 (6.67%)

0.097

CACE

EM(NI)

Complete-Case

MICE

Mean

SD

Mean

SD

Mean

SD

θ1n1 − θ0n1 =0.250

0.250(0.00%)

0.027

0.188 (24.80%)

0.029

0.234(6.40%)

0.029

θ1n0 − θ0n0 =0.150

0.148(1.33%)

0.093

0.089(40.60%)

0.096

0.221(47.33%)

0.084

From Table 3.1 we see that when data is missing completely at random, all
three methods provide unbiased estimates. In the second scenario when the missingness depends on observed data, we can no longer obtain unbiased estimates from
complete-case analysis, whereas both our EM algorithm for nonignorable missing69

ness and MICE designed for data missing at random still provide reasonable estimates as we expected. However, when the missingness of covariates depends not
only on the observed outcome, but also on the partially observed compliance status,
simply using the complete cases or assuming missing at random to impute missing covariates based on the observed data gives us biased estimates of CACE. The
complete-case analysis provides biased estimates due to the fact that it is actually estimating E(Yi (1) − Yi (0) | Ui = c, Ri = 1), which is generally different from
E(Yi (1) − Yi (0) | Ui = c) when the data is not missing completely at random. Imputation based on missingness at random is actually imputing X as if the missing
mechanisms for compliers and always takers assigned to treatment are the same,
and that for compliers and never takers assigned to control are the same. When
this is not the case, the imputation estimates are biased.
From our simulation study, we can see that even if the missingness rate of a
covariate is low (12%), and the compliance class has only a moderate effect on the
missingness, it’s still important and necessary to model the effect of compliance
class on missingness in the analysis, otherwise, the results could be significantly
biased.

3.5

Application to NICU study

The data describes 189,991 babies born prematurely in Pennsylvania between 19952005. These premature babies are the ones whose gestational ages are between 23
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and 37 weeks. The outcome variable we are interested in is neonatal death of babies,
which refers to death during the initial birth hospitalization; we use Yi to represent
the outcome of ith baby in the data set, with Yi being 1 indicating the death of
baby i. We view infants that are delivered in a high level NICU as the treatment
group, whereas the ones that are delivered in a low level NICU are the control
group. Let Di equal 1 if the ith baby is delivered in a high level NICU, 0 if in a low
level NICU. The instrumental variable we consider is whether or not the mother’s
excess travel time that a mother lives from the nearest high level NICU compared
to the nearest low level NICU is less than or equal to 10 minutes. As we discussed
in section 3.2.2, mother’s excess time is a plausible IV in our study which satisfies
the IV assumptions 1-7 in section 3.2.2. We use Zi to denote the IV value for the ith
baby, with Zi being 1 indicating that the excess travel time is less than 10 minutes.
The measured confounders X i for baby i are baby’s gestational age, the month of
pregnancy that prenatal care started and mother’s education. We also include an
intercept in X i .
In this data set, all variables mentioned above are fully observed except the
month of pregnancy that prenatal care started and mother’s education level. The
missing rates for those two covariates are 10.3% and 2.3% respectively. We did ChiSquare tests of independence to test whether the missingness of those two covariates
depends on outcome Y. The p-values are both below 10−15 , strong evidence that
missingness depends on the outcome. We also did logistic regression to test whether
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the missing indicators also depend on the observed risk characteristic of gestational
age given the outcome of neonatal death. The results show that gestational age
has a significant negative association with the missingness of those two covariates
even conditional on outcome (p-values are both below 10−15 ). Since we have strong
evidence that the missingness depends on observed risk characteristics, we believe
that the missingness should also depend on unobserved risk characteristics which
are reflected in compliance status.
Table 3.2 describes the estimated proportions of each compliance class - always
takers, compliers and never takers - for some typical combinations of covariates.
There is a clear trend that as the gestational ages gets larger, the proportion of
always takers gets smaller, and the proportions of the other two compliance classes
gets larger. A reasonable explanation for this phenomenon is that the gestational
age is a strong predictor for the risk of complications as well as death– the smaller
the baby is, the higher risk the baby and mother have. For babies or mothers at
higher risk of complications or death, doctors are more likely to encourage them
to go to a high level NICU no matter the mother lives near one or not, i.e. those
mothers are more likely to be always takers. Notice that from the fit of our model,
there is a substantial proportion of never takers. Although it may be surprising
that people would choose to bypass a high level NICU for a low level NICU (i.e.,
be a never taker). Choice of hospital is driven by a number of factors, including
where a patient’s physician practices; the general view of the hospital by a specific
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community of patients; and what family or friends believe about a hospital. There
are families who choose to deliver at smaller hospitals regardless of where they
live, and their illness severity. This may be because some families are suspicious of
academic hospitals, which make up the majority of high level NICUs, and would
rather travel to deliver at a community hospital even if the hospital has fewer
resources to care for them.
Table 3.3 shows the estimates of parameters in outcome model for compliers,
which are the parameters to estimate the CACE, E(Y (1) − Y (0) | U = c, X = x) =
1
T x)
1+exp (βc0

−

1
T x) .
1+exp (βc1

The standard errors for the corresponding parameters are

provided in parentheses; the standard errors are estimated through bootstrap using
1000 re-samples. From the estimates for the outcome model, we see that larger
gestational age and higher mother’s education level are related to low death rate,
and that for the mothers who started prenatal care late, the baby is at more risk of
death.
Table 3.4 shows the estimated CACE of delivering at high level NICU vs. low
level NICU for various combinations of the measured covariates. High level NICUs
substantially reduce the probability of death for very premature babies. For example, for an infant of gestational age 24 weeks, whose mother started prenatal care
in the second month of pregnancy and has a high school education, being delivered
in a high level NICU will reduce the probability of death by 0.296, with a 95%
confidence interval of -0.429 to -0.137. The effect of high level NICUs is less for less
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2

4

2

4

2

4

30

30

37

37

37

37

4

24

4

2

24

30

4

24

2

2

24

30

Precare

Gestational age

College

College

High School

High School

College

College

High School

High School

College

College

High School

High School

Mother’s education

25.9

26.5

17.0

17.4

70.9

71.1

58.9

59.4

92.2

92.0

87.4

87.2

[25.2, 26.6]

[26.0, 26.9]

[16.5, 17.4]

[17.1, 17.7]

[69.8, 72.1]

[70.1, 72.0]

[57.7, 60.3]

[57.9, 60.2]

[91.5, 92.7]

[91.5, 92.6]

[86.5, 88.3]

[86.3, 88.0]

50.8

48.0

57.3

54.2

15.1

14.0

21.6

20.0

2.9

2.7

4.8

4.4

[49.9, 51.8]

[47.2, 48.8]

[56.6, 58.0]

[53.6, 54.9]

[13.8, 16.4]

[12.8, 15.1]

[19.9, 23.1]

[18.4, 21.4]

[2.4, 3.5]

[2.2, 3.2]

[3.9, 5.6]

[3.6, 5.1]

95%CI

Estimate

Estimate

95%CI

Percentage of compliers

Percentage of always takers

Table 3.2: Percentages of Always Takers, Compliers and Never Takers in %

23.3

25.6

25.8

28.4

13.9

15.0

19.5

21.0

4.9

5.3

7.8

8.4

Estimate

[22.7, 23.9]

[25.1, 26.0]

[25.2, 26.3]

[27.9, 28.8]

[13.3, 14.6]

[14.3, 15.6]

[18.8, 20.3]

[20.2, 21.8]

[4.5, 5.3]

[4.8, 5.7]

[7.3, 8.5]

[7.8, 9.0]

95%CI

Percentage of never takers

premature babies; when the baby’s gestational age is about 37 weeks, the high level
NICU has almost no effect on mortality. This is plausible since a 37 baby is almost
mature and is at less risk, and consequently, the type of delivery NICU may not
matter much.
Using our method, the estimated CACE weighted by the probability of each
combination of the measured covariates is -0.010, with a 95% confidence interval
[-0.014, -0.006]; and the estimated CACE weighted by the number of compliers
in each combination of the measured covariates is −0.002, with a 95% confidence
interval [-0.004, -0.001]. Thus, our analysis shows that high level NICU significantly
reduce the probability of death for premature babies.
We compare our analysis to several ”baseline” methods commonly used to analyze observational studies that are not designed to allow for unmeasured confounders
or nonignorable missingness. The first method we consider is an unadjusted analysis using the observed rates of neonatal death in high level NICUs and low level
NICUs to estimate E(Y | D = 1) − E(Y | D = 0). The estimate is 0.01 with a 95%
confidence interval [0.009, 0.011], which shows that high level NICU is associated
with a higher probability of death. The second method we consider is a logistic
regression model of neonatal death indicator Y on treatment D as well as the measured confounders to get an estimate

1
N

PN

i=1 [Ê(Y

| D = 1, X) − Ê(Y | D = 0, X)]

to adjust for covariates. We use mice under MAR assumption to impute the missing
values in the data. This adjusted estimate is 0.000, with a 95% confidence interval
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[-0.001, 0.001], which provides no evidence of an association between level of NICU
and chance of neonatal death. The third method we consider is subclassification
on the propensity score following Rosenbaum and Rubin (1984). As suggested in
Rosenbaum and Rubin (1984), we divided babies into five subclasses based on the
propensity score, and obtain the average treatment effect by weighting each subpopulation’s average treatment effect by the proportion of each subclass. This adjusted
analysis shows that the high level NICU increases the probability of neonatal death
by 0.002, with a 95% confidence interval [0.001, 0.003]. The conclusions of all the
three baseline methods contradicts with the result of our method, which found evidence that delivery at a high level NICU increases a premature baby’s chance of
survival. Unlike the three baseline methods, our method allows for unmeasured
confounders and a certain type of nonignorable missingness of covariates.
Table 3.3: Estimates of Outcome Model for Compliers
Parameters

Intercept

Gestational age

Precare

Mother’s education

βc1

1.400 (1.617)

-0.153 (0.043)

0.091 (0.063)

-0.522 (0.118)

βc0

9.450 (1.274)

-0.395 (0.042)

0.144 (0.055)

-0.315 (0.113)

3.6

Sensitivity Analysis

In this section, we will assess the sensitivity of our causal conclusions to an unmeasured patient risk characteristic relevant to both the outcome of death and missing-
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Table 3.4: CACE with Different Covariate Values
Gestational age

Precare

Mother’s education

CACE

95% Confidence interval

24

2

High School

-0.296

[-0.429, -0.137]

24

4

High School

-0.343

[-0.490, -0.162]

24

2

College

-0.192

[-0.349, -0.064]

24

4

College

-0.230

[-0.421, -0.077]

30

2

High School

-0.032

[-0.043, -0.017]

30

4

High School

-0.040

[-0.056, -0.023]

30

2

College

-0.019

[-0.033, -0.008]

30

4

College

-0.024

[-0.043, -0.009]

37

2

High School

0.001

[-0.001, 0.002]

37

4

High School

0.001

[-0.001, 0.002]

37

2

College

0.000

[-0.001, 0.001]

37

4

College

0.000

[-0.002, 0.001]

ness of covariates, for example, results of tests like fetal heart tracing or doctor’s
knowledge about mother’s severity of condition. Following the idea of Rosenbaum
and Rubin (1983), we assume that there is an unobserved binary covariate Q which
represents the risk not explained by compliance status and gestational age, and
that is independent of the observed covariates, the compliance status and the instrument. We want to know after accounting for such an unmeasured covariate, is
there still evidence that the high level NICU reduces the probability of death for
babies of small gestational age.
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The adjusted model is as follows:

P (Q = 1) = π,

the parameter π gives the probability that the unobserved binary risk variable being
1. We assume that the unobserved binary risk variable Q is independent of IV Z,
compliance class U and covariates X, thus, the models (3.3.1)-(3.3.6) remain the
same in our sensitivity analysis. The model of outcome controlling also for Q is:
P (Yi (z) = 1 | Ui = u, X i = x, Qi = q) =

T
x + ξuz q)
exp (βuz
T x + ξ q)
1 + exp (βuz
uz

Again, according to assumption 4, βa0 = βa1 , βn0 = βn1 , ξa0 = ξa1 , and ξn0 = ξn1 .
ξuz gives the log odds ratio for Y in two subpopulations q=1 and q=0. Finally, the
model for missing indicators of covariate j controlling further for Q is:
Xi,j

P (Ri
=

(z) = 1 | Yi (z) = y, Ui = u, X i,1,...,k = x1,...,k , Qi = q)

T
exp (θj,u
x1,...,k + γj,u Iy=1 + ηj,u Iz=1 + κj,u q)
T
1 + exp (θj,u x1,...,k + γj,u Iy=1 + ηj,u Iz=1 + κj,u q)

where j = k + 1, ..., m. Based on assumption 6, ηj,a = ηj,n = 0, ∀j = k + 1, ..., m.
κj,u gives the log odds ratio for R in two subpopulations q=1 and q=0.
For fixed sensitivity parameters π, ξuz , κj,u , there exist unique MLEs of the remaining parameters. Our EM algorithm for the original model could be easily
extended to obtain those estimates.

The average treatment effect for compli-

ers of each covariate level is estimated by E(Y (1) − Y (0) | U = c, X = x) =
π · ( 1+exp (β1T x+ξc0 ) −
c0

1
T x+ξ ) )
1+exp (βc1
c1

+ (1 − π) · ( 1+exp1(β T x) −
c0
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1
T x) ).
1+exp (βc1

In order to limit the size of the sensitivity analysis, (κ, ξ) is assumed in the
sensitivity analysis to be the same across all subclasses defined by IV, compliance
class and covariates. And also as in Table 3.4, we estimated CACE for some typical
combinations of the measured confounders under each assignment of (π, κ, ξ).
Table 3.5 presents part of the sensitivity analysis results, showing how the unobserved binary covariate Q affects the CACE for patients with prenatal care starting
at second month of pregnancy, mother’s education being high-school and babies’
gestational age being 24 weeks, 30 weeks and 37 weeks respectively. From Table
3.5, we observe that when the odds ratios are doubled, the estimated CACEs do
not change much in each assignment of sensitivity parameters; and when the odds
ratios are tripled, the estimated CACEs vary more. It’s time consuming to conduct bootstrap for each combination of sensitivity parameters to obtain the 95%
confidence interval for each scenario, however, due to the fact that we are using the
same dataset in outcome analysis in section 3.5 and also in our sensitivity analysis, it is reasonable to assume that the width of the confidence intervals would be
similar to the ones shown in Table 3.4 for each scenario. Specifically, if the point
estimate and the confidence interval for a parameter in Table 3.4 is a and [b, c]
respectively and the point estimate for a corresponding parameter in the sensitivity
analysis tables is d, then we estimate the confidence interval for the parameter in
the sensitivity analysis to be [d-(a-b), d+(c-a)]. For example, in the first case in
Table 3.5, where the gestational age is 24, precare is 2, and mother’s education

79

level is high school, if 10% of patients’ unobserved risk covariate is 1, and the unobserved covariate doubles both odds ratios for Y and missingness indicators R,
the estimated CACE is -0.289, with approximate 95% confidence interval [–0.422,
-0.130]. Consequently, the unobserved covariate Q, would have to more than triple
the odds in both the outcome and missing indicator models, before altering the
conclusion obtained in section 3.3.5 that high level NICUs reduce the probability
of death in babies of small gestational age. To provide some idea about how large
an effect an unobserved covariate would have to have to change our conclusions,
we compare the effect to that of the observed covariate gestational age, which is
a strong predictor for death and risk of complications. According to the fit of our
model (see Table 3.3), if gestational age is changed by 2 weeks, then the odds ratios
for the outcome death would be altered by a factor of 2.2 and the odds ratios for the
response would be altered by a factor of 1.6. Thus based on our sensitivity analysis
results, an unobserved covariate with the same effect as changing gestational age by
2 weeks would not change our conclusion that high level NICUs reduce the probability of death in babies of small gestational age. We conclude that even if some
confounders, for instance, results of tests like fetal heart tracing, doctor’s knowledge
about mother’s severity of condition, are unmeasured and affect both the outcome
and missingness of covariates, they would not change our conclusions unless they
had very large effects.
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3.7

Summary

We proposed a series of models to estimate the causal effect of a treatment using
an instrumental variable when the missingness of covariates may depend on the
fully observed outcome, fully observed covariates, IV as well as the partially observed compliance behavior. Simulation studies show that under our nonignorable
missingness assumption where the missingness depend on partially observed compliance class, even if the missing rate of covariate is low (12%), and the effect of
compliance class on the missingness is only moderate, the commonly used estimation methods, complete case analysis and multiple imputation by chained equations
assuming MAR, could provide substantially biased estimates; in contrast, our proposed method, which is designed to deal with nonignorable missingness of covariate,
provides unbiased results.
In this chapter, we have developed a maximum likelihood method for instrumental variable estimation with nonignorable missingness of covariates. Further
research could consider a Bayesian version of our model which would enable carrying our multiple imputation based on our model.
We applied our method to an observational study of neonatal care that aims
to estimate the delivery effect on mortality of premature babies being delivered
in a high level NICU vs. a low level NICU. We found that high level NICUs
substantially reduce the death risk for babies with small gestational age, which
implies that high level NICUs are truly providing considerably better care for babies
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with small gestational age. Therefore, it is valuable to invest resources to strengthen
the perinatal regionalization system for those babies. For babies that are almost
mature, strengthening the perinatal regionalization system should probably not be
a priority.
The methods we develop in this chapter may be useful for many other observational studies facing unmeasured confounders as well as nonignorable missing data
like ours. One example we described in the introduction is comparative effectiveness
studies where it is a concern that the missingness of important lab values might be
related with compliance status. For these settings, our simulation study shows that
it is important and necessary to model the effect of compliance status on missingness
to get valid estimates.
In this study, we focus on cases which contain missing covariates, and the missingness of covariates is nonignorable. However, in practice, many studies face the
issue of not only missing covariates but also missing outcomes. In our nonignorable
missingness assumption (Assumption 6), we allow the missingness of covariates to
depend on the outcome. If there are also missing outcomes, since the covariates
are predictors for the outcome, it is likely that the missingness of the outcome
is related to the values of covariates which are unobserved for some subjects. If
missingness exists in both the covariates and the outcome, identifiability is a major
issue to study since the missingness of the covariates and outcome may depend on
each other. Additional assumptions beyond what we have considered are needed
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for identifiability. Possible assumptions could be developed based on Peng, Little
and Raghunathan (2004) where missingness of outcome is allowed to depend on
compliance and fully observed data whereas missingness of covariates is allowed to
depend on only the fully observed data but not compliance status.
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Table 3.5: Effects of Q on the CACE for patients with prenatal care starting at second month of pregnancy, mother’s education being high-school and with gestational
age being 24 weeks, 30 weeks and 37 weeks respectively
Gestational age

24

Effect of Q on Y

exp(ξ)=2

exp(ξ)= 21

exp(ξ)=3

exp(ξ)= 31

30

exp(ξ)=2

exp(ξ)= 21

exp(ξ)=3

exp(ξ)= 31

37

exp(ξ)=2

exp(ξ)= 21

exp(ξ)=3

exp(ξ)= 31

Effect of Q on R

P (Q = 1) : π
0.1

0.5

0.9

exp(κ)=2

-0.289

-0.283

-0.290

exp(κ)= 21

-0.297

-0.296

-0.293

exp(κ)=2

-0.293

-0.296

-0.297

exp(κ)= 21

-0.290

-0.283

-0.289

exp(κ)=3

-0.273

-0.228

-0.217

exp(κ)= 31

-0.296

-0.252

-0.225

exp(κ)=3

-0.298

-0.329

-0.379

exp(κ)= 31

-0.289

-0.300

-0.352

exp(κ)=2

-0.032

-0.031

-0.031

exp(κ)= 21

-0.032

-0.033

-0.032

exp(κ)=2

-0.032

-0.033

-0.032

exp(κ)= 21

-0.031

-0.031

-0.032

exp(κ)=3

-0.029

-0.024

-0.022

exp(κ)= 31

-0.032

-0.026

-0.022

exp(κ)=3

-0.032

-0.038

-0.046

exp(κ)= 31

-0.032

-0.035

-0.043

exp(κ)=2

0.001

0.001

0.001

exp(κ)= 21

0.001

0.001

0.001

exp(κ)=2

0.001

0.001

0.001

exp(κ)= 21

0.001

0.001

0.001

exp(κ)=3

0.001

0.001

0.001

exp(κ)= 31

0.001

0.001

0.001

exp(κ)=3

0.001

0.001

0.001

exp(κ)= 31

0.001

0.001

0.001
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Chapter 4
Aporetic Conclusions When
Testing the Validity of an
Instrumental Variable

4.1

Testing untestable assumptions in causal inference with instrumental variables

4.1.1

What is an instrument? What assumptions underlie
its use?

An instrument is a haphazard nudge to accept a treatment where the nudge can affect the outcomes only to the extent that it alters the treatment received. The most
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basic example is Holland’s (1988) randomized encouragement design, in which people are randomized to one of two groups, and members of one group are encouraged
to adopt some health promoting behavior, say quit smoking, but the outcome, say
an evaluation of lung tissue, might respond to a reduction in cigarettes consumed
but not to encouragement to quit that leaves cigarette consumption unchanged.
There are two key elements here. First, in the encouragement experiment, people
are picked at random for encouragement — selection does not just look haphazard,
it is actually randomized — so the comparison of encouraged and unencouraged
groups is equitable, not subject to biases of self-selection. Even in the randomized
encouragement design, people who change their behavior, quit smoking, are a selfselected part of the encouraged and possibly unencouraged groups, so a comparison
of quitters and others could be very biased: quitters may be more self-disciplined
in all areas of their lives and may be more concerned with health promotion. The
second element is that encouragement works, affects the outcome, only if it changes
behavior, the so-called exclusion restriction. Stated informally in words, the instrumental variable (IV) estimate, the Wald estimate, attributes the entire difference
in outcomes between the randomized encouraged and unencouraged groups to the
greater change in behavior in the encouraged group, thereby avoiding biases of selfselection. If the encouraged group has a mean outcome that is one unit better than
the mean in the unencouraged group, and if half of the encouraged quit while none
of the unencouraged quit, then the Wald estimator claims the effects of quitting on
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those who quit when encouraged is two units, because encouragement only affected
half of those who were encouraged. See Angrist, Imbens and Rubin (1996) for an
equivalent formal statement.
So there are two key elements in the randomized encouragement design:

(i)
(ii)

encouragement is randomized,
encouragement affects only those individuals who change their behavior in
response to encouragement, the exclusion restriction.

In the encouragement design, (i) is ensured by the use of randomization, and (ii)
seems highly plausible because of what we think we know about the relationships
that might exist between advice, behavior and lung tissue.

Typical applications

of the reasoning involving instruments are less compelling, sometimes much less
compelling, because (i) is not ensured by actual random assignment, and (ii) is less
firmly grounded in other things we think we know. In particular, (i) is typically
rendered somewhat plausible by adjusting for visible differences in measured pretreatment covariates between encouraged and unencouraged groups, but of course
this strategy may fail to control a covariate that was not measured.

Typically,

the encouraged and unencouraged groups are not formed by random assignment,
but rather in a way that appears irrelevant and haphazard, but these appearances
may deceive.

Typically, the exclusion restriction seems plausible to anyone who

cannot imagine a way encouragement could affect the outcome without altering the
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treatment, but this may simply reflect inadequate imagining. So it is natural to
want to test the assumptions that define an instrument.
Instruments are increasingly used in the study of health outcomes; see, for example, McClellan et al. (1994), Lalani et al. (2010) and Lorch et al. (2012). Outside of
randomized clinical trials, the treatment a patient receives may reflect a physician’s
judgment about the best treatment for this patient or else a patient’s preference
for a particular treatment.

Instruments are used in health outcomes research in

the hope of finding circumstances in which attributes of the patient do not decide
treatment assignment, and instead something haphazard and irrelevant decides the
treatment. For instance, if a patient has a heart attack and lives far from a hospital capable of performing coronary bypass surgery, then the heart attack may be
treated without bypass surgery just because of where the patient happens to live.
Obviously, geography might appear to be haphazard and irrelevant, might appear
to satisfy conditions (i) and (ii), yet these appearances may be incorrect; so, testing
(i) and (ii) is important. For several recent discussions of instrumental variables
in health outcomes, see Baiocchi et al. (2010), Brookhart and Schneeweiss (2007),
Cheng et al. (2011), Swanson and Hernán (2013) and Tan (2006).

4.1.2

Untestable assumptions?

The assumptions required for an instrument are often said to be untestable (e.g.,
Stock 2002, §4.1).

Whether this is true or not depends in part on what one
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means by untestable.

Assumptions might be said to be untestable if they (A)

are premises of a theorem that is the basis for an inference, (B) these premises
are not self-evident or implied by other premises that are self-evident, (C) these
premises cannot be tested against data from the observable distributions specifically
mentioned in the statement of the theorem. This is an internally consistent way to
use the word untestable, but it is a manner of speaking at considerable tension with
typical scientific practice. Typically in science, each new claim to know something
is checked for consistency with the other things we think we know.

There is

no reason to confine this checking for consistency to the short list of premises of a
theorem. This checking may involve logical consistency, but more often the question
is whether the new knowledge claim and old knowledge claims could plausibly be
describing one and the same world, or whether something has to give. We discuss
an example in detail in §4.2. In practical work with instruments, it is quite common
to hear people announce that IV assumptions are untestable and then to see them
do the sorts of checks that test IV assumptions.
Why are IV assumptions often said to be untestable when people often test
them? We suspect there is a reason. A test of IV assumptions may lead neither
to rejection of the assumptions nor to acceptance but rather to an aporia.
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4.1.3

Aporia: mutually inconsistent but individually plausible claims

The Oxford American Dictionary defines the noun aporia as “an irresolvable internal
contradiction . . . in a text, argument or theory,” with aporetic as the adjective. A
collection of propositions, $1 , . . . , $L is an aporia if each $` is plausible on its own
but they are jointly inconsistent, that is, $1 ∧ . . . ∧ $L is false or implausible; see
Rescher (2009).

A special case of aporia occurs in mathematical reasoning in a

proof by contradiction, in which one proves ∼ $L by showing that $1 , . . . , $L−1 are
certainly true and $1 , . . . , $L is aporetic in yielding a contradiction. In contrast,
in a typical aporia, in the general case, the identity of the culpable proposition or
propositions is unknown. In Plato’s early dialogues, Socrates would invalidate the
views of his opponents by demonstrating that those views were aporetic; see Vlastos
(1994, p. 58).
To recognize that one’s beliefs contain an aporia is an advance in understanding,
albeit an uncomfortable one. From a false premise, one can logically deduce every
conclusion, true or false (because, in elementary propositional logic, A ⇒ B is true
for all B if A is false).

To believe $1 , . . . , $L individually but fail to recognize

them as aporetic is to risk logically deducing false propositions from beliefs one
holds (because one believes $1 , . . . , $L , can deduce the false proposition A = $1 ∧
. . . ∧ $L from one’s beliefs, and can deduce any B from A because A is false). To
recognize that one’s beliefs $1 , . . . , $L are aporetic is to recognize that one harbors
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at least one false belief, to be motivated to identify that belief, and to be hesitant in
deducing consequences from $1 , . . . , $L . To recognize an aporia is an advance in
understanding, and it is certainly better than believing the component propositions
without recognizing their aporetic status.
One can escape an aporia $1 , . . . , $L by arbitrarily discarding propositions $`
until the remaining propositions are no longer inconsistent. In this process, there is
nothing to ensure that one has discarded false propositions and retained true ones.
Rather, one has narrowed the scope of one’s beliefs to the point that one is committed to sufficiently few beliefs that one is safe from accusations of inconsistency.
For instance, one can avoid an aporia in testing the assumptions of IV by defining
those assumptions so narrowly that they become untestable.

4.1.4

Outline: an IV study; a test of IV assumptions; two
technical innovations

We are currently using an instrument in a study of the possible effects of delivery by cesarean section of extremely premature infants of 23-24 weeks gestational
age.

Some background is discussed in §4.2.1 and the IV analysis is presented in

§4.2.2-§4.2.4. In §4.2.5, the IV assumptions are tested, resulting in an aporia that
is discussed in detail.

The two appendices present two technical innovations: a

new simpler approach to strengthening an instrument, and a sensitivity analysis for
an attributable effect closely related to the Wald estimator. A reader who wishes
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to reproduce the analysis reported here will need to consult these appendices. We
placed this material in the appendix because we wanted to emphasize the conceptual discussion of aporetic conclusions when testing the assumptions underlying
instrumental variables.

4.2

Does delivery by cesarean section improve
survival of extremely premature neonates?

4.2.1

Background: Studies of cesarean section without an
instrumental variable

We are currently engaged in a study of the possible effects of cesarean section on
the survival of very premature babies of 23-24 gestational age. For reasons to be
described shortly, we tried to find an instrument for delivery by cesarean section and
to check its validity by contrast with other trusted information. Some terminology
and background are needed.
The gestational age of a full-term baby is 39 weeks or 9 months. Babies born
under 37 weeks gestation are considered premature, with infants born younger having more medical problems, requiring more intensive medical care to survive, and
having a higher likelihood of long-term neurodevelopment and medical problems.
This issue is most prominent for the infants at the limits of viability, that is, those
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infants born at 23 and 24 weeks gestation. Babies born between 23 and 24 weeks of
gestational age are very premature and face high risks of death and life-long health
problems even with special care.

A fetus of 23 and 24 weeks of gestational age

that is not born alive is defined as a fetal death, whereas an infant who dies after
delivery is designated as a neonatal death. There are clinical indicators around a
pregnancy at the limits of viability that give the physician information about the
likelihood that an infant will survive first the delivery, and then the initial period
of time after delivery.
In clinical epidemiology, the phrase “confounding by indication” is often defined
as the bias introduced when patients receive medical treatments based on pretreatment indications that the patient would benefit from the treatment. To the extent
that such indications for treatment are incompletely recorded, thus incompletely
controlled by adjustments for recorded pretreatment differences, they may lead to
bias in elementary analyses that rely on adjustments for confounding factors using recorded pretreatment differences. At gestational age 23-24 weeks, delivery by
cesarean section is likely to reflect clinical judgement about the clinical stability
and likelihood of survival of the infant and the generally unrecorded preferences of
the mother. Both of these factors are likely to be incompletely recorded in most
large-scale population datasets.
A major use of instrumental variables in medicine is to break up or otherwise
avoid confounding by indication, that is, to find some circumstances in which pa-
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tients received a medical treatment for reasons other than that the patient was
expected to benefit from treatment. In a randomized trial, patients receive treatments for no reason at all, the flip of a fair coin, and instruments are sought in
observational studies to recover as best one can some aspects of the randomized
situation.
Existing literature suggests that routine or optional use of cesarean delivery for
babies of ≥ 30 weeks gestational age is not of benefit to the baby. For instance,
Werner et al. (2013) concluded:
In this preterm cohort, cesarean delivery was not protective against poor
outcomes and in fact was associated with increased risk of respiratory
distress and low Apgar score compared with vaginal delivery.

(page

1195)
More than seventy percent of the preterm cohort in Werner et al. (2013) were
≥ 30 weeks gestational age, and more than half were ≥ 32 weeks, while less than
6% were less than 26 weeks. Werner et al. (2013) compared babies delivered by
cesarean section and babies delivered vaginally adjusting for measured covariates
using logit regression. For instance, women on Medicaid were more likely to deliver
vaginally with an odds ratio of 1.43, while women with third party insurance (e.g.,
Blue Cross) were more likely to deliver by cesarean section with odds ratio 1.46,
and additive adjustments on the logit scale were intended to correct for this. Using
similar methods and focusing on premature babies of ≥ 32 weeks gestational age,
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Malloy (2009) reached similar findings.
In contrast, for very premature infants of 22-25 weeks gestational age, Malloy
(2008) concluded: “Cesarean section does seem to provide survival advantages for
the most immature infants. . . ” (page 285). As in the other studies, the comparison
was of babies delivered by one method or the other with adjustments for measured
covariates by logit regression.
With varied emphasis, these studies note the problem of confounding by indication. They note that a direct comparison of babies delivered by cesarean section
and babies delivered vaginally could be biased by aspects of the baby and the mother
that led to the decision to deliver by one method rather than the other, and this is
true even if logit regression is used to adjust for measured covariates. The decision
to perform a cesarean section in one case but not in another may reflect indications
that were evident to the physicians or mothers involved but not evident in measured covariates. This seems especially likely when a complex choice is made in a
thoughtful, deliberate way. For a baby of gestational age 23-24 weeks, these considerations may include a medical judgement about the viability of the baby, and a
mother’s concern for a baby who may face severe life-long health problems. When
studying a survival outcome, one is especially concerned about comparing groups of
babies that may have been constructed with the viability of those babies in mind.
One might prefer circumstances in which more or fewer babies were delivered by
cesarean section for reasons that had nothing to do with the particular situation of
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the baby and mother.
The finding that cesarean sections did not benefit more mature preterm babies
did not stir up much controversy, but the finding of benefit for very premature
babies was more controversial and surprising. We set out to study this using an
instrument for cesarean section among babies 23-24 weeks of gestational age.

4.2.2

An instrument: variation among hospitals in the use
of cesarean section for older babies

As noted in §4.2.1, confounding by indication occurs when patients receive treatments for good reasons, for instance because a physician believes giving the treatment to this patient will benefit this patient. It turns out that the use of cesarean
section varies substantially from one hospital to the next. A mother may deliver
by cesarean section not because of anything unique to her but simply because she
delivers at a hospital that makes more extensive use of cesarean section.
Our instrument is the predicted c-section rate among babies of 23-24 weeks
gestational age at the hospital where the baby was delivered. The rate is predicted
using logit regression with four predictors. Three predictors describe the hospital’s
use of c-sections for older babies, that is: (a) the rate among babies with gestational
age 25-32 weeks, (b) the rate among babies with gestational age 33-36 weeks, (c)
the rate among babies with gestational age 37+ weeks. The fourth predictor was
(d) the malpractice insurance rate in the county in which the hospital was located.
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There is evidence that cesarean sections are more common in regions where the risk
of malpractice litigation is greater; e.g., Dubay, Kaestner, and Waidmann (1999),
Baicker, Buckles, and Chandra (2006) and Yang et al. (2009).

The continuous

instrument was the predicted probability from the logit regression. The value of
this instrument would have been constant within a hospital but for predictor (d)
which varied from year to year, so the instrument was constant in a given hospital in
a given year, and was describing the proclivity of the hospital to perform c-sections
rather than anything about a particular baby or mother.

4.2.3

Matching to strengthen the instrument

Available pretreatment covariates described the mother (e.g., her age), her baby
(e.g., birth weight), the mother’s Census tract (e.g., median household income),
and the hospital.

Hospitals vary in their abilities to care for premature infants.

In particular, neonatal intensive care units (NICUs) are graded into seven levels of
care based on available technology to care for sicker newborn patients. We matched
exactly for the level of the NICU; see Table 4.1. We also used logit regression to estimate a hospital’s risk-adjusted rates of two complications, thrombosis and wound
infection, and matched to balance these variables.

These scores were estimated

from older babies, ≥ 25 weeks gestational age, so the scores make no use of outcomes for the group under study, namely babies of 23-24 weeks gestational age.
The literature has suggested these two factors, thrombosis and wound infection, as
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measures of the quality of care provided by the obstetrical hospital. In brief, the
matching sought to compare similar mothers and babies from similar neighborhoods
at similar hospitals.
Matched pairs were formed to be similar in terms of covariates and very different
in terms of the instrument.

Specifically, each of 1489 pairs contained two babies

of 23-24 weeks gestational age, one at a hospital with a high frequency of use of
c-sections for older babies, the other with a low frequency of use of c-sections for
older babies. So the high and low groups looked similar in measured covariates, but
one group went to hospitals that often delivered by c-section for older babies and
the other group went to hospitals that used c-sections sparingly. As seen in Tables
4.1-4.3, the 1489 babies in the high group and the 1489 babies in the low group were
similar in terms gestational weeks (23 or 24), birth weight, year of birth, mother’s
age, mother’s education, mother’s race/ethnicity, mother’s health insurance, the
technical level of the hospital’s neonatal intensive care unit (NICU), pregnancy
complications such as hypertension and oligohydramnios, number of prenatal care
visits, parity, month that prenatal care started, various aspects of the mother’s
census tract. In Table 4.1, the three covariates were matched exactly. In Table
4.2, the five covariates had identical marginal distributions but were not exactly
matched, a condition known as “fine balance.” In Table 4.3, the difference in means
for the covariates was never more than a tenth of a standard deviation, while the
difference in the instrument was more than three standard deviations.
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This is

depicted for three continuous covariates and the instrument in Figure 1.
The matching was done in a new but simple way described in Appendix C. The
approach taken here is a small extension and slight simplification of the approach
taken in Zubizarreta et al. (2013).

Described informally, nonoverlapping high

and low instrument groups were defined by cutting the instrument in three places,
discarding the middle. High and low babies were then selectively matched to push
the groups further apart on the instrument, balance the covariates, and produce
close individual pairs. The match was the solution to a constrained optimization
problem.

4.2.4

Outcomes: c-section and mortality rates

The instrument is intended to manipulate one outcome, whether or not a baby is
delivered by cesarean section, with possible effects on another outcome, mortality
of the baby. As intended and expected, the instrument did manipulate the rate of
cesarean sections; see Table 4.4. Table 4.4 counts pairs, not babies, in the manner
that is commonly associated with McNemar’s test; see Cox (1970). More than half
the babies in both the high and low groups were delivered vaginally, but the 24.6%
c-section rate in the low group was increased by more than half to 38.2% in the
high group. When the two babies in a pair were delivered in different ways, the
odds were 396/194 = 2.04 to 1 that the high baby had the c-section.
Table 4.5 displays the main outcome, namely total in-hospital mortality. Table
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4.5 is examining the possible effects of delivering at a high c-section hospital rather
than a low c-section hospital, not yet the effects of c-sections themselves. The point
estimate of the odds ratio favoring survival at a hospital with a high c-section rate is
360/185 = 1.95. In the high group, survival rate was 34.8% and in the low group it
was 23.0%, or a difference of 360−185 = 175 survivors. If one believed naively that
the matching in Tables 4.1-4.3 and Figure 1 had reproduced a paired randomized
experiment that assigned one baby in each pair at random to the high hospital and
the other to the low hospital (i.e., if one believed (i) but perhaps not (ii) in §4.1.1),
then, using the method in Rosenbaum (2002, §6), one would be 95% confident that
A ≥ 132 babies were caused to survive because of delivery at a high hospital. (This
is a one-sided 95% confidence interval derived from the randomization distribution,
but if one prefers a two-sided interval, then the one-sided 97.5% interval is A ≥ 124
babies rather than 132. In a paired randomized experiment, A is an unobserved
random variable; see Rosenbaum (2002) or on-line Appendix II.) Moving away from
the naive model for treatment assignment (i.e., moving away from (i) in §4.1.1), if
an unobserved covariate doubled the odds of delivery at a high hospital and doubled
the odds of survival, then the one-sided 95% confidence interval is A ≥ 66 babies
were caused to survive because of delivery at a high hospital. (More precisely, the
95% interval is A ≥ 66 at Γ = 1.25 by the method in Rosenbaum (2002), and this
amplifies to (Λ, ∆) = (2, 2) by the method in Rosenbaum and Silber (2009).) If an
unobserved covariate doubled the odds of delivery at a high hospital and quadrupled
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the odds of survival, then the one-sided 95% confidence interval is A ≥ 23 babies
were caused to survive because of delivery at a high hospital (or technically, this is
the 95% interval at Γ = 1.25 which amplifies to (Λ, ∆) = (2, 4)). The ostensible
effects of delivering at a high rather than low c-section hospital are not sensitive to
small departures from random assignment. So far, nothing has been said about the
effects of c-sections, only about the effects of delivering at hospitals that do more
of them.
In Table 4.4, the high c-section hospitals did D = 396 − 194 = 202 more csections than did the low c-section hospitals and 175 more babies survived. If the
high-versus-low grouping were a valid instrument for delivery by c-section, then the
Wald estimator would attribute the additional survivors at high c-section hospitals
to the additional c-sections at those hospitals, that is, ignoring sampling variability,
175 additional survivors attributed to 202 additional c-sections. Assuming that the
high-versus-low grouping is a valid instrument (that is, assuming both (i) and (ii)
in §4.1.1), the Wald estimate of the effect of c-sections on the survival of babies who
receive them because they were born at high c-section hospitals is 175/202 = 0.87,
an impressive ratio, not quite one more survivor for one more c-section.

There

is substantial sampling variability and possible bias in assignment to high or low
hospitals, and both must be addressed, the first using a confidence statement, the
second using sensitivity analysis. An interesting quantity is A/D where A is the
attributable effect in the previous paragraph and D is number of additional c-

101

sections at high c-section hospitals.

The 95% confidence intervals for A/D are

A/D ≥ 132/202 = 0.65 for randomization inference (Γ = 1), A/D ≥ 66/202 = 0.33
for an unobserved covariate that doubled the odds of delivering at a high c-section
hospital and doubled the odds of survival (Γ = 1.25), and A/D ≥ 23/202 = 0.11
for an unobserved covariate that doubled the odds of delivering at a high c-section
hospital and quadrupled the odds of survival (Γ = 1.5). (In on-line Appendix II,
it is noted that A/D is the ratio of an unobserved to an observed random variable
and a confidence interval for it is discussed.)
The exclusion restriction would be false if high c-section hospitals were more
aggressive in many ways in their efforts to save babies of 23-24 weeks gestational
age and if some of the reduced mortality were due to other aspects of the care
provided at high c-section hospitals. Is the exclusion restriction compatible with
other things we think we know?

4.2.5

A test of the exclusion restriction

As discussed in §4.2.1, the literature claims that there is no benefit from cesarean
section for older preterm babies, say 30-34 weeks gestational age. Presuming —
that is, tentatively and uncritically assuming — that claim to be true, we tested
the exclusion restriction by redoing the study for babies of 30-34 weeks gestational
age. It is important to realize that the literature is based on direct comparisons
of babies delivered by c-section and babies delivered vaginally, whereas we used
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an instrument, and there are other differences to be discussed in a moment.

So

we are really asking whether different methodologies concur in saying c-sections
benefit babies at 23-24 weeks gestational age and not at 30-34 weeks gestational
age, or whether an aporia has been produced, in which it is not reasonable to
believe everyone’s methodology, in the literature and our own, is producing correct
conclusions about the effects of c-sections.
There were, of course, many more babies born at 30-34 weeks gestational age
and the mortality rate was much lower.

We matched in a manner similar to

that in §4.2.3, but because there were many more babies involved, we made more
extensive use of exact matching.

This produced 23631 pairs of babies of 30-34

weeks gestational age with covariate balance and instrument separation similar to
that seen in Tables 4.1-4.3 and Figure 1 for the younger babies.
As before for babies of 23-24 weeks gestational age, the instrument worked for
babies of 30-34 weeks gestational age, with high babies more likely than low babies to
be delivered by cesarean section. The mortality results appear in Table 4.6. After
noting that the mortality rates are very different in Tables 4.5 and 4.6, one notes also
that high babies had lower mortality rates than low babies in both tables, and the
odds ratios are somewhat different in magnitude but neither is small, 360/185 = 1.95
for 23-24 weeks and 1076/672 = 1.60 for 30-34 weeks. We also looked for a trend,
and indeed the odds ratio is larger at 30 weeks gestational age and smaller at 34
weeks. We redid the study again for babies of 25-29 weeks gestational age, finding
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mortality results between Tables 4.5 and 4.6.
So the claims in the literature and our results sound plausible and reasonable if
taken one at a time, but they cannot all be correct inferences about the effects of
cesarean section on mortality. The conclusion is an aporia, individually plausible
claims that are mutually incompatible. Of course, many things could have gone
wrong, either in the literature or in our study. In our study, the two assumptions
required of an instrument might be false. The literature implicitly assumes that
if one takes account of observed covariates, say by logit regression, then one has
reproduced a randomized experiment (or formally, they implicitly assume ignorable
treatment assignment), and that assumption gets people in no end of trouble in
observational studies. Are there other possibilities?
Indeed, there is another possibility.

The cited literature in §4.2.1 focused on

neonatal deaths, excluding fetal deaths, whereas we looked at all deaths.

If a

woman was pregnant with a baby of 23-24 weeks gestational age and the pregnancy
terminated at that time, then we did not distinguish a death moments before birth
and a death moments after birth. Remember that a baby of 23-24 weeks gestational
age will require substantial medical assistance to remain alive.

To our minds,

the death of a baby of 23-24 weeks gestational age is a biological event, whereas
the classification of that death as before or after birth may be little more than
bookkeeping, perhaps an attempt to reduce the emotional pain of an event that is
typically distressing for the mother.
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Because our findings differ from the literature, we separated fetal and neonatal
deaths, as shown in Tables 4.7 and 4.8. Consider what Tables 4.7 and 4.8 would
look like if one removed all pairs with at least one fetal death, that is, removed the
first row and first column of each table.

The remaining babies would be either

alive or neonatal deaths, the outcomes studied in the existing literature. Indeed,
the resulting tables would then agree with the existing literature, in that c-sections
would look beneficial in Table 4.7 but not in Table 4.8. By contrast, including fetal
deaths, c-sections look beneficial in both tables.

Arguably, a death of a fetus of

23-24 weeks gestational age is a death of an extremely premature baby, a biological
event, whereas the classification of that death into a fetal death or a neonatal death
is partly a style of practice and a manner of speaking. Arguably, fetal deaths should
not be excluded from all deaths, as they were not excluded in Tables 4.5 and 4.6.
The available evidence is aporetic.

Each part looks plausible on its own but

the parts are mutually inconsistent. Something has to give, but it is less than clear
what that something should be. The literature finds a benefit from c-sections at
23-24 weeks gestational age but not at 30-34 weeks gestational age. The literature
makes no effort to address unmeasured biases in the selection of individual babies
for delivery by cesarean section, though biases at the individual level are at least
plausible, perhaps more plausible than not.

In contrast, our analysis uses an

instrument to avoid selection biases operating at the level of individual babies,
using the frequency of c-sections among older babies at a hospital as an instrument
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for c-sections among babies of 23-24 weeks gestational age. Hospitals with higher
frequencies of c-sections have somewhat lower mortality, and this difference is not
sensitive to small biases of selection into high or low c-section hospitals. By virtue
of assuming the exclusion restriction, the Wald estimator attributes higher survival
to higher rates of c-sections, producing a point estimate of 87%, and that seems
implausibly large — that is, 87% of c-sections save babies who would otherwise have
died — however, confidence intervals include substantially smaller effects.

The

exclusion restriction could easily be false here if hospitals that do more c-sections
also are more aggressive in other ways in their treatment of extremely premature
infants — the exclusion restriction would wrongly attribute the effects of those other
efforts to c-sections. Our results would look much more like the existing literature
if we followed the literature in ignoring fetal deaths at 23-24 weeks gestational age,
counting only neonatal deaths at 23-24 weeks gestational age, but we worry that
in many cases the distinction between a fetal death and a neonatal death at 23-24
weeks gestational age is a distinction without much of a difference. The element
that seems least ambiguous in all this is that hospitals that do more c-sections have
lower total mortality at 23-24 weeks gestational age, a difference that is not easily
attributed to small biases in selection of mothers into hospitals, although it could
conceivably be explained by moderately large biases.

Whether this difference is

caused by c-sections or by something else these hospitals are doing is not as clear.
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4.3

Summary

We have suggested that the assumptions of the instrumental variable argument are
often testable providing an aporia is seen as an acceptable conclusion. An aporia
is a collection of individually plausible but mutually incompatible propositions.
An aporia is an advance in understanding, albeit an uncomfortable one.

In the

example, the result of testing the exclusion restriction is a heightened concern that
the exclusion restriction may be false, and the IV analysis may be wrong, but also
a heightened concern that some of the things we think we know from the literature,
some of the things we assumed in testing the exclusion restriction, may themselves
be false.
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Table 4.1: Three variables were exactly matched in forming 1489 pairs of two babies
with gestational ages 23-24 weeks, namely gestational age (23 or 24 weeks), the
capability or level of the neonatal intensive care unit (NICU), and the year of birth
(1993-2005). The table gives counts of babies, and these are identical in the high
and low instrument group defined by the estimated probability of a c-section at a
given hospital.

Instrument Group
High

Low

Gestational age in weeks
23 weeks

726

726

24 weeks

763

763

NICU Level
1

333

333

2

56

56

3A

126

126

3B

480

480

3C

438

438

3D

15

15

FC

41

41

Year of birth
1993

30

30

1994

47

47

1995

90

90

1996

89

89

1997

104

104

1998

124

124

1999

133

133

2000

132

132

2001

129

129

2002

166

166

2003

188

188

2004

132

132

2005

125

125
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Table 4.2: Five variables were finely balanced in forming 1489 pairs of two babies
with gestational ages 23-24 weeks, meaning that these variables had the same marginal
distributions in the high and low instrument groups, so the counts are identical. The
table gives counts of babies, and these are identical in the high and low instrument
group defined by the estimated probability of a c-section at a given hospital.

Instrument Group
High

Low

Mother had hypertension during pregnancy
Yes

75

75

No

1437

1437

Yes

52

52

No

1308

1308

Oligohydramnios

Mother’s race/ethnicity
Non-Hispanic White

551

551

Non-Hispanic Black

305

305

Hispanic

478

478

Non-Hispanic Asian/P. Islander

87

87

Other

36

36

Missing

32

32

8th grade or less

128

128

Some high school

249

249

High school graduate

473

473

Some college

303

303

College graduate

164

164

More than college (MS, PhD)

108

108

Missing

64

64

Mother’s education

Mother’s health insurance
Fee for service

116

116

HMO

647

647

Federal/State

662

662

Other

20

20

Uninsured

42

42

Missing

2

2
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Table 4.3: Covariates balanced in mean only and forced imbalance in mean in the
instrument in forming 1489 pairs of two babies with gestational ages 23-24 weeks. The
table gives the mean of each covariate or instrument before and after matching, together
with the difference in means divided by the standard deviation before matching (S-Dif).
For Yes/No = Y/N variables, 1=Yes, 0=No. RAHR = risk adjusted hospital rate.
PROM = premature rupture of membrane.
Before matching
Mean
High

S-Dif
Low

After matching
Mean
High

S-Dif
Low

Hospital Covariates
Hospital delivery volume (#)

2850

2903

-0.03

2568

2722

-0.09

RAHR of thrombosis

0.00

0.00

0.31

0.00

0.00

0.09

RAHR of wound infection

0.00

0.00

0.18

0.00

0.00

-0.05

Mother/Baby Covariates
Birth weight (grams)

591.12

577.25

0.16

587.08

580.31

0.08

Hypertension (Y/N)

0.07

0.04

0.12

0.05

0.05

0.00

Chorioamnionitis (Y/N)

0.28

0.26

0.04

0.27

0.26

0.02

28.15

26.89

0.19

27.69

27.61

0.01

Prenatal care visits (#)

7.04

5.89

0.27

6.52

6.32

0.05

Prenatal care missing (Y/N)

0.09

0.05

0.14

0.07

0.05

0.07

Parity

1.90

1.90

-0.00

1.91

1.77

0.09

Parity missing (Y/N)

0.01

0.01

0.02

0.01

0.01

0.03

Month prenatal care started

2.00

2.16

-0.14

2.00

2.12

-0.10

Month care started missing (Y/N)

0.08

0.04

0.20

0.06

0.04

0.09

Multiple delivery

1.27

1.19

0.15

1.22

1.18

0.09

Congenital (Y/N)

0.15

0.14

0.04

0.15

0.14

0.03

Placentation (Y/N)

0.23

0.20

0.07

0.22

0.20

0.04

Diabetes (Y/N)

0.03

0.03

0.00

0.03

0.03

-0.03

Pre-term labor (Y/N)

0.81

0.74

0.17

0.80

0.76

0.09

PROM (Y/N)

0.35

0.28

0.15

0.33

0.30

0.08

Small for gestation age (Y/N)

0.09

0.12

-0.11

0.09

0.12

-0.09

Mother’s age (years)

Neighborhood Covariates from the Census
Household median income ($)

45024

41435

0.21

44730

44848

-0.01

Income missing (Y/N)

0.00

0.00

0.03

0.00

0.00

0.00

Below Poverty Level (fraction)

0.11

0.16

-0.10

0.15

0.16

-0.03

0.22

3.12

Instrumental variable
C-sec. predicted prob.

0.38
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0.23

2.56

0.40

Table 4.4: C-sections in 1489 matched pairs of babies of 23-24 weeks gestational
age. The table counts pairs, not babies. As expected, c-section rates are higher in
the high c-section group.
Low Baby
High Baby

C-section

Other

Total

High Baby Rate

C-section

173

396

569

38.2%

Other

194

726

920

61.8%

Total

367

1122

1489

Low Baby Rate

24.6% 75.4%

100.0%

Table 4.5: Mortality in 1489 matched pairs of babies of 23-24 weeks gestational age.
The table counts pairs, not babies. Mortality rates are higher in the low c-section
group.
Low Baby
High Baby

Dead

Alive Total

Dead

786

185

971

65.2%

Alive

360

158

518

34.8%

Total

1146

343

1489

Low Baby Rate

77.0%

23.0%

111

High Baby Rate

100.0%

Table 4.6: Mortality in 23631 matched pairs of babies of 30-34 weeks gestational
age. The table counts pairs, not babies. Mortality rates are higher in the low
c-section group.
Low Baby
High Baby

Dead

Alive

Total

High Baby Rate

Dead

108

672

780

3.3%

Alive

1076

21775 22851

96.7%

Total

1184

22447 23631

Low Baby Rate

5.0%

95.0%

112

100.0%

Table 4.7: Mortality by type of death in 1489 matched pairs of babies of 23-24 weeks
gestational age. The table counts pairs, not babies. Mortality rates are higher in
the low c-section group.

Low Baby
High Baby

Fetal Death

Neonatal Death

Alive

Total

High Baby Rate

Fetal Death

111

99

47

257

17.2%

Neonatal Death

220

356

138

714

48.0%

Alive

141

219

158

518

34.8%

Total

472

674

343

1489

Low Baby Rate

31.7%

45.3%

23.0%

113

100.0%

Table 4.8: Mortality by type of death in 23631 matched pairs of babies of 30-34
weeks gestational age. The table counts pairs, not babies. Mortality rates are higher
in the low c-section group.

Low Baby
High Baby

Fetal Death

Neonatal Death

Alive

Total

High Baby Rate

Fetal Death

64

6

298

368

1.6%

Neonatal Death

26

12

374

412

1.7%

Alive

692

384

21775

22851

96.7%

Total

782

402

22447

23631

Low Baby Rate

3.3%

1.7%

95.0%

114

100.0%

Birth weight
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Figure 1: The match was intended to balance covariates and imbalance the instrument, and the boxplots
depict this for three continuous covariates – mother’s age, birth weight, and number of prenatal visits –
and for the continuous instrument – the estimated probability of a c‐section at the hospital predicted
from c‐section rates for older babies.
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Appendix A
Two-Stage Censoring by Death

A.1

Bounds of the SACE

Given the value of π1100 , the linear programming problem (2.3.14)-(2.3.20) has a
q

π

1100
solution if and only if the set Φ = [max{q110|1 − π1000 , π1111111|1
},
+π1110 +π1010

is not empty, which is essentially

q110|1
p10|1

≥

q111|1
,
p11|1

q110|1 π1100
]
π1100 +π1000

an inequality that must be satisfied
q

π

1100
based on assumptions 4-6. If Φ is not empty, let T = max{q110|1 −π1000 , π1111111|1
},
+π1110 +π1010

T =

q110|1 π1100
,
π1100 +π1000

the solution to the linear programming problem is,

max((π1111 E(Yi (1) | 1111) + π1110 E(Yi (1) | 1110) + π1100 E(Yi (1) | 1100)) | π1100 )
=

q111|1 (π1111 + π1110 )
+T
π1111 + π1110 + π1010

(A.1.1)
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min((π1111 E(Yi (1) | 1111) + π1110 E(Yi (1) | 1110) + π1100 E(Yi (1) | 1100)) | π1100 )



q
π1100


if 111|1
≤T
T

π1010




(A.1.2)
= q111|1 + (1 − π1010 )Ṫ if q111|1 π1100 ≥ T

π1100
π1010






q
π

q
+ (1 − π1010 )T̈ if T < 111|1 1100 < T
111|1

π1100

π1010

where
Ṫ =

T̈ =





T

ifπ1010 ≤ π1100




T

ifπ1010 > π1100





T

ifπ1010 ≤ π1100




 q111|1 π1100

ifπ1010 > π1100

π1010

Thus, given a fixed value of π1100 , the bounds for the SACE are given by:
min(SACE | π1100 ) =

max(SACE | π1100 ) =

min((π1111 E(Yi (1) | 1111) + π1110 E(Yi (1) | 1110) + π1100 E(Yi (1) | 1100)) | π1100 ) − (q111|0 + q110|0 )
π1111 + π1110 + π1100
max((π1111 E(Yi (1) | 1111) + π1110 E(Yi (1) | 1110) + π1100 E(Yi (1) | 1100)) | π1100 ) − (q111|0 + q110|0 )
π1111 + π1110 + π1100

From section 2.3.1, we know that π1100 is not point identified, but bounded:
π1100 ∈ I, I = [max{0, p11|0 + p10|0 − p10|1 }, min{p10|0 , p10|1 }], we have,

min SACE =

max SACE =

min

[

min((π1111 E(Yi (1) | 1111) + π1110 E(Yi (1) | 1110) + π1100 E(Yi (1) | 1100)) | π1100 ) − (q111|0 + q110|0 )
]
π1111 + π1110 + π1100

max

[

max((π1111 E(Yi (1) | 1111) + π1110 E(Yi (1) | 1110) + π1100 E(Yi (1) | 1100)) | π1100 ) − (q111|0 + q110|0 )
]
π1111 + π1110 + π1100

π1100 ∈I

π1100 ∈I

One can prove that the expression on the left side of equation (A.1.2) is continuous as a function of π1100 and both the functions on the left side of equations (A.1.1)
and (A.1.2) are non-decreasing as functions of π1100 . Thus, the max SACE could be
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achieved when π1100 is min{p10|0 , p10|1 } which is the right end point of the range for
π1100 , and the min SACE could be achieved when π1100 is max{0, p11|0 +p10|0 −p10|1 }
which is the left end point of the range for π1100 . Based on this observation, we can
obtain the formula for the bound of SACE which is given in (2.3.21) and (2.3.22).

A.2

The ARDSNet data

861 patients were randomized to receive mechanical ventilation with either lower
tidal volume or traditional tidal volume. The lower tidal volume group contained
432 patients and the traditional tidal volume group contained 429 patients. We
created our variables based on the recorded answers for the study termination form
and weaning form.
The first time point (day 28) survival information is obtained through the
“ST2DT” variable in the study termination sub-dataset which recorded the date of
death. If the date of death for subject i is below day 28, then S1i is 0 and the QOL
is not defined; otherwise, S1i is 1.
For the patients who survive to day 28, the QOL that whether patient was able to
breathe without assistance by day 28 was well defined. The variable ”UNASSIST” in
the study termination sub-dataset recorded whether the patient was able to sustain
unassisted breathing for ≥ 48 hours during the first 28 days after initiation of study
procedures. However, even if the patient sustained unassisted breathing for at least
48 hours, the patient could return to assisted breathing before day 28. The variable
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”ASSIST” recorded this information. If the patient returned to assisted breathing
from unassisted breathing for at least 48 hours, the ”ASSIST” was recorded as
”Yes”. Thus, for patients whose ”UNASSIST” was recorded as ”No”, we view
them as the ones who were not able to breathe without assistance by day 28. For
patients whose ”UNASSIST” was recorded as ”Yes”, and ”ASSIST” was recorded
as ”No”, we view them as the ones who were able to breathe without assistance by
day 28; for patients whose ”UNASSIST” was recorded as ”Yes” and ”ASSIST” was
recorded as ”Yes”, each patient could either (a) have had unassisted breathing at
some point and then returned to assisted breathing and still be on assisted breathing
at day 28 or (b) have had unassisted breathing before day 28, returned to assisted
breathing before day 28 and then returned to unassisted breathing before day 28.
For these patients, we further use the weaning sub-dataset which recorded in detail
about each patients’ breathing status to figure out whether the patient was able to
breathe without assistance by day 28.
Our second time point survival indicator is whether the patient was eventually
discharged home with unassisted breathing. This information was recorded in the
variable ”STATUS” which described patient status at study termination.
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Appendix B
IV with Nonignorable Missing
Covariates

B.1

E-step Estimates

The fomulas to update N in E step are as follows, ∀x2 , x3 , x4 , y
N1,1,x2 ,x3 ,x4 ,a,0,y = N Nx2 ,x3 ,x4 ,1,0,y
N1,1,x2 ,x3 ,x4 ,n,1,y = N Nx2 ,x3 ,x4 ,0,1,y
EN1,1,x2 ,x3 ,x4 ,a,1,y = N Nx2 ,x3 ,x4 ,1,1,y

P1,1,x2 ,x3 ,x4 ,a,1,y
P1,1,x2 ,x3 ,x4 ,a,1,y + P1,1,x2 ,x3 ,x4 ,c,1,y

EN1,1,x2 ,x3 ,x4 ,c,1,y = N Nx2 ,x3 ,x4 ,1,1,y

P1,1,x2 ,x3 ,x4 ,c,1,y
P1,1,x2 ,x3 ,x4 ,a,1,y + P1,1,x2 ,x3 ,x4 ,c,1,y

EN1,1,x2 ,x3 ,x4 ,n,0,y = N Nx2 ,x3 ,x4 ,0,0,y

P1,1,x2 ,x3 ,x4 ,n,0,y
P1,1,x2 ,x3 ,x4 ,n,0,y + P1,1,x2 ,x3 ,x4 ,c,0,y

EN1,1,x2 ,x3 ,x4 ,c,0,y = N Nx2 ,x3 ,x4 ,0,0,y

P1,1,x2 ,x3 ,x4 ,c,0,y
P1,1,x2 ,x3 ,x4 ,n,0,y + P1,1,x2 ,x3 ,x4 ,c,0,y
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P0,1,x ,x ,x ,a,0,y
EN0,1,x2 ,x3 ,x4 ,a,0,y = N 3x2 ,x4 ,1,0,y Px3 =q3 2 3 4
x3 =1 P0,1,x2 ,x3 ,x4 ,a,0,y
P0,1,x ,x ,x ,n,1,y
EN0,1,x2 ,x3 ,x4 ,n,1,y = N 3x2 ,x4 ,0,1,y Px3 =q3 2 3 4
x3 =1 P0,1,x2 ,x3 ,x4 ,n,1,y
EN0,1,x2 ,x3 ,x4 ,a,1,y = N 3x2 ,x4 ,1,1,y Px3 =q3

P0,1,x2 ,x3 ,x4 ,a,1,y
P
3
P0,1,x2 ,x3 ,x4 ,a,1,y + xx33 =q
=1 P0,1,x2 ,x3 ,x4 ,c,1,y

EN0,1,x2 ,x3 ,x4 ,c,1,y = N 3x2 ,x4 ,1,1,y Px3 =q3

P0,1,x2 ,x3 ,x4 ,c,1,y
P
3
P0,1,x2 ,x3 ,x4 ,a,1,y + xx33 =q
=1 P0,1,x2 ,x3 ,x4 ,c,1,y

EN0,1,x2 ,x3 ,x4 ,n,0,y = N 3x2 ,x4 ,0,0,y Px3 =q3

P0,1,x2 ,x3 ,x4 ,n,0,y
P
3
P0,1,x2 ,x3 ,x4 ,n,0,y + xx33 =q
=1 P0,1,x2 ,x3 ,x4 ,c,0,y

EN0,1,x2 ,x3 ,x4 ,c,0,y = N 3x2 ,x4 ,0,0,y Px3 =q3

P0,1,x2 ,x3 ,x4 ,c,0,y
P
3
P0,1,x2 ,x3 ,x4 ,n,0,y + xx33 =q
=1 P0,1,x2 ,x3 ,x4 ,c,0,y

x3 =1

x3 =1

x3 =1

x3 =1

P1,0,x ,x ,x ,a,0,y
EN1,0,x2 ,x3 ,x4 ,a,0,y = N 4x2 ,x3 ,1,0,y Px4 =q4 2 3 4
x4 =1 P1,0,x2 ,x3 ,x4 ,a,0,y
P1,0,x ,x ,x ,n,1,y
EN1,0,x2 ,x3 ,x4 ,n,1,y = N 4x2 ,x3 ,0,1,y Px4 =q4 2 3 4
x4 =1 P1,0,x2 ,x3 ,x4 ,n,1,y
EN1,0,x2 ,x3 ,x4 ,a,1,y = N 4x2 ,x3 ,1,1,y Px4 =q4

P1,0,x2 ,x3 ,x4 ,a,1,y
P
4
P1,0,x2 ,x3 ,x4 ,a,1,y + xx44 =q
=1 P1,0,x2 ,x3 ,x4 ,c,1,y

EN1,0,x2 ,x3 ,x4 ,c,1,y = N 4x2 ,x3 ,1,1,y Px4 =q4

P1,0,x2 ,x3 ,x4 ,c,1,y
P
4
P1,0,x2 ,x3 ,x4 ,a,1,y + xx44 =q
=1 P1,0,x2 ,x3 ,x4 ,c,1,y

EN1,0,x2 ,x3 ,x4 ,n,0,y = N 4x2 ,x3 ,0,0,y Px4 =q4

P1,0,x2 ,x3 ,x4 ,n,0,y
P
4
P1,0,x2 ,x3 ,x4 ,n,0,y + xx44 =q
=1 P1,0,x2 ,x3 ,x4 ,c,0,y

EN1,0,x2 ,x3 ,x4 ,c,0,y = N 4x2 ,x3 ,0,0,y Px4 =q4

P1,0,x2 ,x3 ,x4 ,c,0,y
P
4
P1,0,x2 ,x3 ,x4 ,n,0,y + xx44 =q
=1 P1,0,x2 ,x3 ,x4 ,c,0,y

x4 =1

x4 =1

x4 =1

x4 =1

P0,0,x2 ,x3 ,x4 ,a,0,y
EN0,0,x2 ,x3 ,x4 ,a,0,y = N Bx2 ,1,0,y Px4 =q4 Px3 =q
3
x4 =1
x3 =1 P1,0,x2 ,x3 ,x4 ,a,0,y
P0,0,x2 ,x3 ,x4 ,n,1,y
EN0,0,x2 ,x3 ,x4 ,n,1,y = N Bx2 ,1,0,y Px4 =q4 Px3 =q
3
x4 =1
x3 =1 P1,0,x2 ,x3 ,x4 ,n,1,y
EN0,0,x2 ,x3 ,x4 ,a,1,y = N Bx2 ,1,1,y Px4 =q4 Px3 =q3
x4 =1

x3 =1

P0,0,x2 ,x3 ,x4 ,a,1,y
Px =q Px =q
P0,0,x2 ,x3 ,x4 ,a,1,y + x44 =14 x33 =13 P0,0,x2 ,x3 ,x4 ,c,1,y
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EN0,0,x2 ,x3 ,x4 ,c,1,y = N Bx2 ,1,1,y Px4 =q4 Px3 =q3

P0,0,x2 ,x3 ,x4 ,c,1,y
Px =q Px =q
P0,0,x2 ,x3 ,x4 ,a,1,y + x44 =14 x33 =13 P0,0,x2 ,x3 ,x4 ,c,1,y

EN0,0,x2 ,x3 ,x4 ,n,0,y = N Bx2 ,1,1,y Px4 =q4 Px3 =q3

P0,0,x2 ,x3 ,x4 ,n,0,y
Px =q Px =q
P0,0,x2 ,x3 ,x4 ,n,0,y + x44 =14 x33 =13 P0,0,x2 ,x3 ,x4 ,c,0,y

EN0,0,x2 ,x3 ,x4 ,n,0,y = N Bx2 ,1,1,y Px4 =q4 Px3 =q3

P0,0,x2 ,x3 ,x4 ,c,0,y
Px =q Px =q
P0,0,x2 ,x3 ,x4 ,n,0,y + x44 =14 x33 =13 P0,0,x2 ,x3 ,x4 ,c,0,y

x4 =1

x4 =1

x4 =1

x3 =1

x3 =1

x3 =1
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Appendix C
Testing IV Assumptions

C.1

A new bipartite matching algorithm for
strengthening an IV

Following Baiocchi et al. (2010) and Zubizarreta et al. (2013), we used matching to
strengthen the instrumental variable while balancing observed covariates. However,
we changed, simplified, and in some contexts improved, a key element. These two
papers both took a single population, discarded part of the population, split the
remainder into pairs, where the pairs balance covariates while being far apart on the
instrument. Discarding a middle portion, an ambiguous portion, of the population
makes the instrument stronger, improving its design sensitivity, making the study
less sensitive to bias from nonrandom assignment of encouragement; see Small and
Rosenbaum (2008). Traditionally, splitting a single population into pairs is called
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by the awkward name “nonbipartite matching” which means “not two parts.” The
history of the awkward name involves the fact that optimal two-part matching (e.g.,
treatment versus control matching), so called optimal bipartite matching, was studied and solved first; see Korte and Vygen (2008) for a textbook discussion of both
problems with comprehensive references. Baiocchi et al. (2010) used an algorithm
and Fortran code for optimal nonbipartite matching created by Derigs (1988), as
implemented in Lu et al.’s (2011) R package nbpmatching; it minimizes the total
distance within pairs formed from a single population, discarding a portion of the
population using a technical trick called “sinks”. Zubizarreta et al. (2013) used integer programming, specifically Zubizarreta’s (2012) mipmatch package, to impose
additional linear constraints on the nonbipartite match, such as requiring nominal
covariates to be perfectly balanced or requiring means of continuous covariates to
be close. Also, Zubizarreta et al. (2013) changed the optimized objective function
along the lines suggested in Rosenbaum (2012), so as to optimize the number of
individuals discarded.

A feature of the nonbipartite approach is that individual

pairs are far apart on the instrument, but the high baby in one pair may be lower on
the instrument than the low baby in some other pair. Depending upon the nature
of the instrument and the covariates, that feature may or may not be reasonable. It
might be reasonable if the meaning of the instrument changed with the levels of the
covariate. In the current study, with an instrument defined in terms of a hospital’s
rate of use of c-sections in older babies, this feature did not seem reasonable.
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We wanted each and every baby in the high group to have a higher value of the instrument than each and every baby in the low group. This change was implemented
in a simple way using bipartite matching. We cut the population into three groups
based on the value of the instrument, V , where the middle group, 0.29 ≤ V ≤ 0.31
contained 10% of the population and was discarded.

Write {α1 , . . . , αh , . . . , αH }

for the H remaining babies in the high group and {β1 , . . . , β` , . . . , βL } for the L
remaining babies in the low group, noting that Vαh > Vβ` for every h, `. We then
matched babies in the high group to babies in the low group to be close in terms
of a covariate distance, δh` , measuring how similar baby αh and baby β` were in
terms of covariates, and far apart on the instrument, with δh` = ∞ if Vαh − Vβ` < ω
for an ω > 0. The covariate distance combined a robust Mahalanobis distance for
covariates with δh` = ∞ for mismatches on the variables in Table 1. Write ah` = 1
if baby αh in the high group is paired with baby β` in the low group, ah` = 0
otherwise, so that we require ah` ∈ {0, 1},

PH

i=1

ai` ≤ 1,

PL

j=1

ahj ≤ 1, for each h,

`. In principle, one could simply minimize the total distance within matched pairs,
PH PL
h=1

`=1

ah` δh` , subject to

PH PL
h=1

`=1

ah` = min (H, L), and this could be done

using the optimal assignment algorithm — e.g., Bertsekas’ (1981) auction algorithm
as made available in the pairmatch function of Hansen’s (2007) optmatch package
in R. Alternatively, one could make ω larger, as we did, to further strengthen the instrument, discarding some babies to achieve this more stringent objective. This can
be done using the same software for the assignment algorithm without constrain-
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ing

PH PL
h=1

`=1

ah` and instead minimizing

PH PL
h=1

`=1

ah` δh` −λ

PH PL
h=1

`=1

ah` for

specified λ > 0, and this determines an optimal number of babies to discard; see
Rosenbaum (2012) for extensive specifics.
As in Zubizarreta (2012) and Zubizarreta et al. (2013), we used integer programming, not the optimal assignment algorithm, to minimize
λ

PH PL
h=1

`=1

ah` but with additional linear constraints.

PH PL
h=1

`=1

ah` δh` −

As in these references,

these added constraints forced the fine balance in Table 4.2 and the close mean
match seen in Table 4.3. Moreover, we added a new constraint to further strengthen
the instrument. Setting δh` = ∞ if Vαh − Vβ` < ω forces each matched pair to differ
by ≥ ω in terms of the instrument. The new additional constraint forced the mean
difference in the instrument V to differ by a larger number, Ω > ω, so every pair
meets the minimum requirement of ω, but on average a larger difference of Ω is
achieved. The new constraint was

C.2

PH PL
h=1

`=1

ah` (Vαh − Vβ` − Ω) > 0.

Confidence intervals and sensitivity analyses
for A/D

Section 4.2.4 of the paper reported confidence intervals for ratios of survival effects
to differences in the frequency of use of c-sections. These intervals are new but are
a direct extension of an existing method. This appendix describes the new method
and briefly indicates its justification. There are I matched pairs, i = 1, . . . , I, of two
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subjects, j = 1, 2, one encouraged, Zij = 1, the other not, Zij = 0, so Zi1 + Zi2 = 1
for each i.

In §4.2.3, there are I = 1489 pairs of two babies, one at a high c-

section hospital, Zij = 1, the other at a low c-section hospital, Zij = 0. Pairs were
matched for observed covariates xij , so xi1 = xi2 for each i, but the matching may
have failed to control an unobserved covariate uij , so possibly ui1 6= ui2 for many or
all i. Baby ij has two potential binary responses (rT ij , rCij ), one rT ij if encouraged
with Zij = 1, the other rCij if unencouraged with Zij = 0.

In §4.2.4, rT ij = 1

if baby ij would survive at the high c-section hospital in the ith pair, rT ij = 0
otherwise, and rCij = 1 if baby ij would survive at the low c-section hospital in
the ith pair, rCij = 0, otherwise.

Fisher’s (1935) sharp null hypothesis of no

treatment effect asserts H0 : rT ij = rCij for all babies ij — in words, switching from
a low c-section hospital to a high c-section hospital does not change any baby’s
survival.

In a randomized paired experiment with binary response, McNemar’s

test is the randomization test of Fisher’s H0 .

Each baby is observed under one

treatment, so the effect of the treatment, rT ij − rCij , is not observed for any baby;
see Neyman (1923), Welch (1937) and Rubin (1974). An important unobservable
quantity in §4.2.4 is the attributable effect A =

PI

i=1

P2

j=1

Zij (rT ij − rCij ); it is the

unobservable number of babies caused to survive by virtue of delivering at the high
c-section hospital. In constructing one-sided confidence intervals for A, we follow
Angrist, Imbens and Rubin (1996) in additionally assuming rT ij ≥ rCij , so a 23-24
week baby who would survive with the stress of a vaginal delivery, rCij = 1, would
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also survive with the reduced stress of a cesarean delivery, rT ij = 1. A two-sided
interval for A may be constructed from two one-sided intervals. Under Fisher’s null
hypothesis of no effect, every rT ij − rCij = 0, so A = 0 no matter how treatments
Zij are assigned.
Similarly, (dT ij , dCij ) is the binary indicator of delivery by cesarean section or
vaginal delivery (1 for c-section, 0 for vaginal delivery) at the high and low csection hospital.

Baby ij is said to be a complier if encouragement shifts the

baby’s delivery in the encouraged direction, that is, if 1 = dT ij > dCij = 0, so
this baby would be delivered by c-section at the high c-section hospital in pair i
and would be delivered vaginally at the low c-section hospital in pair i. Baby ij
is said to be an always taker if dT ij = dCij = 1, a never taker if dT ij = dCij = 0,
and a defier if 0 = dT ij < dCij = 1, and we follow the usual practice of assuming
there are no defiers, dT ij ≥ dCij , so a baby who would be delivered by c-section at
a low c-section hospital would also be delivered by c-section at a high c-section
hospital; see Angrist, et al. (1996) for discussion of this terminology.

Write

F = {(rT ij , rCij , dT ij , dCij , xij , uij ) , i = 1, . . . , I, j = 1, 2} and Z for the event that
Zi1 + Zi2 = 1 for each i. In a randomized paired encouragement design, encouragement Zij is assigned by Pr (Zi1 = 1 | F, Z) = 1/2, Zi2 = 1 − Zi1 , and assignments
in distinct pairs are independent.

A simple model for sensitivity analysis in ob-

servational studies has 1/ (1 + Γ) ≤ Pr (Zi1 = 1 | F, Z) ≤ Γ/ (1 + Γ) for specified
Γ ≥ 1, Zi2 = 1 − Zi1 , with independent assignments in distinct pairs, so ran-
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domization inference corresponds with Γ = 1; see Rosenbaum (1987; 2002, §4) for
discussion of this method of sensitivity analysis, and for other methods, see Cornfield et al. (1959), Rosenbaum and Rubin (1983), Gastwirth (1992), Marcus (1997),
Small (2007), Yu and Gastwirth (2005), Hosman et al. (2010), and Liu et al. (2013).
Write Rij for the baby ij’s observed survival response, Rij = Zij rT ij +(1 − Zij ) rCij ,
and Dij for the observed delivery, Dij = Zij dT ij + (1 − Zij ) dCij . Appendix Table
1 renumbers the two babies in a pair so Zi1 = 1, Zi2 = 0, and then records the joint
distribution of (Ri1 , Di1 , Ri2 , Di2 ) = (rT i1 , dT i1 , rCi2 , dCi2 ).
As I → ∞ in a randomized encouragement design, for fixed α, 0 < α < 1,
e such
conventionally α = 0.05, it is possible to find an observed random variable A


e holds with
e F, Z tends to a probability ≥ 1 − α, so that A ≥ A
that Pr A ≥ A
95% confidence, that is, the unobserved attributable effect A is at least equal to
e except in at most 100α% of experiments; see Rosenbaum (2002) for specifics
A
and Weiss (1955) for general discussion of confidence sets for unobserved random
variables in terms of observed random variables. Moreover, in a sensitivity analysis
in an observational study, if the bias in treatment assignment is at most Γ ≥ 1, then


eΓ such that Pr A ≥ A
eΓ F, Z tends to a
there is an observed random variable A
probability ≥ 1 − α as I → ∞; again, see Rosenbaum (2002).
The exclusion restriction says that encouragement that does not change the
delivery (dT ij , dCij ) does not change the response (rT ij , rCij ), that is, rT ij = rCij
whenever dT ij = dCij .

Stated informally, the exclusion restriction says that if
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high c-section hospitals sometimes save the lives of babies, then they do it by
performing c-sections not by doing something else. The exclusion restriction could
easily be false: high c-section hospital could be more aggressive in many ways in
trying to save the lives of babies of 23-24 weeks gestational age, and c-sections
may produce only a part or even none of the survival effect of generally more
aggressive treatment. The exclusion restriction places a series of constraints on the
relationship between the observed appendix Table C.1 and the unobservable table
recording (rCi1 , dCi1 , rCi2 , dCi2 ).

The unobserved table is called the pivot table.

Consider, for example, the 44 pairs in the first row and first column of the observed
appendix Table C.1. Because the exclusion restriction says rT ij = rCij whenever
dT ij = dCij , those 44 pairs could be in the same place in the pivot table or some
could move to the third and fourth row of the first column, but none could move
to the second row.

Also, pairs in the second row could move to the fourth row.

In fact, the only differences that can exist between the observed and pivot tables
are the movements just described. Under the exclusion restriction, A is the total
number of pairs that are in the first row of the observed table and in the fourth row
of the pivot table.
Let bij = 1 if rT ij > rCij and dT ij > dCij , and bij = 0 otherwise. If bij = 1, then
baby ij would survive receiving a c-section at the high c-section hospital in pair i
and would die without a c-section at the low c-section hospital in pair i.

Using

the exclusion restriction, rT ij − bij (dT ij − dCij ) = rCij , and the attributable effect
PI P2
PI P2
is A =
The mean
i=1
j=1 Zij (rT ij − rCij ) =
i=1
j=1 Zij bij (dT ij − dCij ).
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difference in survival is:
Tr

I

2

I

2

I

2

I

2

=

1 XX
1 XX
Zij Rij − (1 − Zij ) Rij =
Zij {rCij + bij (dT ij − dCij )} − (1 − Zij ) rCij
I i=1 j=1
I i=1 j=1

=

1 XX
1 XX
(2Zij − 1) rCij +
Zij bij (dT ij − dCij )
I i=1 j=1
I i=1 j=1

=

1 XX
A
(2Zij − 1) rCij + .
I i=1 j=1
I

I

2

In a randomized paired encouragement experiment, E ( Zij = 1 | F, Z) = 1/2 so
that
E


I X
2
1X
I

(2Zij − 1) rCij F, Z





= 0, and E



i=1 j=1

A
F, Z
I


=

I
2
1 XX
(rT ij − rCij ) = τ
2I i=1 j=1

so that Tr and A/I are both unbiased for the average effect of encouragement, τ ;
however, departures from random assignment (i.e., failures of (i) in §4.1.1) can introduce bias. The observable random variable Td =

1
I

PI

i=1

P2

j=1

Zij Dij −(1 − Zij ) Dij

is the difference between the number of c-sections performed by the high and low
c-section hospitals; in Table 4.4 it is Td = 396 − 194 = 202. It is a descriptive,
not a causal quantity: it describes what happened, not what would happen. The
Wald estimator is Tr /Td .

For the Wald estimate to work, encouragement must

increase the frequency of what is encouraged so that Td converges in probability to
a strictly positive quantity δ > 0 as I → ∞, and that is assumed here; therefore,
with high probability, high c-section hospitals have done more c-sections among the
I pairs than low c-section hospitals for sufficiently large I, and Pr ( Td ≤ 0 | F, Z)
is negligible for large I. The quantity
PI
W = PI

i=1

i=1

P2

j=1

P2

j=1

Zij bij (dT ij − dCij )

Zij Dij − (1 − Zij ) Dij

= PI

i=1
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A
P2

j=1

Zij Dij − (1 − Zij ) Dij

=

A/I
Td

is the number of babies caused to survive by a c-section in a high c-section hospital
as a fraction of the number of additional c-sections performed by high c-section
hospitals. Now, W is the ratio of an unobservable random variable A/I, a causal
quantity, and an observed random variable Td , a descriptive quantity, so W is
unobservable.

The quantity W is directly interpretable on its own; however, it

might reasonably be regarded as the intended finite sample estimand of the Wald
estimator, in the sense that Tr /Td and W both converge in probability as I → ∞
to the average effect of c-sections on compliers if encouragement is randomized
within pairs; see Angrist et al. (1996) for discussion of this estimand. Given the
n
o
e Γ with Pr A ≥ A
e Γ F, Z ≥ 1 − α for
large sample confidence interval, A ≥ A
sufficiently large I, and continuing to regard Pr (Td ≤ 0 | F, Z) is negligible for
n
o
n
o
e Γ /Td F, Z = Pr W ≥ A
e Γ /Td F, Z ≥ 1 − α
large I, we have Pr A/Td ≥ A
e Γ /Td was reported in §4.2.4.
for sufficiently large I. The confidence interval W ≥ A
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Table C.1: Mortality Rij and mode of delivery Dij (C = C-section, V = vaginal)
in 1489 matched pairs of babies of 23-24 weeks gestational age. For the high baby
with Zij = 1, mortality is Rij = rT ij and delivery is Dij = dT ij , whereas for the
low baby with Zij = 0, mortality is Rij = rCij and delivery is Dij = dCij . To avoid
notational ambiguity, in this table j is changed so the first baby, j = 1, is the high
baby. The table counts pairs, not babies.
Low Baby, Zi2 = 0

High Baby, Zi1 = 1

C-Alive

C-Dead

V-Alive

V-Dead

rCi2 = 1

rCi2 = 0

rCi2 = 1

rCi2 = 0

dCi2 = 1 dCi2 = 1 dCi2 = 0 dCij = 0

C-Alive, rT i1 = 1, dT i1 = 1

44

54

37
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C-Dead, rT i1 = 0, dT i1 = 1

37

38

36

179

V-Alive, rT i1 = 1, dT i1 = 0

31

35

46

127

V-Dead rT i1 = 0, dT i1 = 0

47

81

65

488
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